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1. INTRODUCTION 
1.1. Sepsis 
1.1.1. Incidence of sepsis 
Sepsis and SIRS (systemic inflammatory response syndromes) are the leading causes of 
death in intensive care units (ICUs). In industrialized countries, it has an average 
incidence of 300/100.000 per year, increasing significantly in the elderly (Martin, 
Mannino et al. 2003; Engel, Brunkhorst et al. 2007). Despite many improvements in 
ICU patient therapy, there is still no effective therapy for sepsis, outside of the classic 
catecholamine therapy, which however does not decrease the lethality of sepsis-patients; 
which lies between 40 and 70% (Bolton, Young et al. 1993). In the United States, 
approximately 600.000 patients develop sepsis per year and about 240.000 of these 
patients will succumb to the disease (Angus, Linde-Zwirble et al. 2001). Due to the 
smaller total population number, the number of sepsis and SIRS incidences in Germany 
is about a quarter of those in the USA (Engel, Brunkhorst et al. 2007). Reasons for the 
rise of sepsis cases are both that patients grow older and that the number of patients 
with immunodeficiency is increasing. Whether increasing resistance of microorganisms 
is a contributing factor is still in debate.  
 
1.1.2. Definition of sepsis 
Though the term sepsis is linked closely to modern intensive care, the medical concept 
is rather older. The word "sepsis" was first introduced by Hippocrates (ca. 460-370 BC) 
and is derived from the Greek word sipsi ("make rotten"). Ibn Sina (979-1037 BC) 
observed the coincidence of blood putrefaction (septicaemia) and fever. This concept of 
sepsis which was introduced in classical antiquity was used until the 19th century. In 
1914, Schottmüller gave a clinical definition of sepsis: Sepsis occurs in cases of 
permanent or periodical invasion of pathogenic germs into the blood circulation 
(Schottmüller 1914). Later in 1980, sepsis was defined as the release of humoral and 
cellular mediators from the host by Schuster and Werdan (Schuster HP 2005). 
In 1991, a consensus conference held by the American College of Chest Physicians 
(ACCP) and the Society of Critical Care Medicine (SCCM) took place with the aim of 
agreeing on a set of definitions that could be applied to patients with sepsis and its 
sequelae. This concept is used mainly by clinicians and researchers for the purposes of 
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clinical trial design for more than 20 years now (Bone, Balk et al. 1992). Some 
definitions of this concept are given below. 
SIRS is defined by a variety of severe clinical insults such as trauma, burns, and 
pancreatitis. The response is manifested by two or more of the following conditions of 
systemic inflammation: fever or hypothermia (temperature >38°C or <36°C), 
tachycardia (heart rate >90 beats/min without hypovolemia), and tachypnea or a 
supranormal minute ventilation (respiratory rate >20 breaths/min or PaCO2 <32mmHg), 
leukocytosis or leucopenia (WBC >12.000 cells/nl, <4.000 cells/nl, or >10% immature 
(band) forms). Sepsis is defined as a systemic inflammatory response syndrome (SIRS) 
plus a documented infection. Severe sepsis however is defined as sepsis with organ 
dysfunction, hypoperfusion or hypotension. Another term, “septic shock” indicates 
severe sepsis with hypotension, despite adequate fluid resuscitation. 
Infection/Bacteraemia describes an infection, which does not meet SIRS conditions. 
Multiple Organ Dysfunction Syndrome (MODS) occurs by altered organ function in an 
acutely ill patient such that homeostasis cannot be maintained without intervention. 
Though SIRS presents the clinical manifestation of released pro-inflammatory cytokines 
in the early stage of inflammation, this could also occur by non-infectious processes 
such as drug reaction and overdose. This makes the SIRS concept not specific for 
sepsis. An alternative to this concept was developed, in 2001 at the International Sepsis 
Definitions Conference providing a practical frame for defining the systemic 
inflammation caused by infection. They created the so-called PIRO concept which 
combines and analyzes different stages of sepsis by four criteria: predisposition, 
infection, response to the infectious challenge, and organ dysfunction (Howell, Talmor 
et al. 2011). Although these definitions have proved valuable, it is still difficult to 
systematically stage the severity of sepsis.  
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1.1.3. Pathophysiology of sepsis 
1.1.3.1. General aspects  
1.1.3.1.1. General aspects of immune response  
 
Although the body is constantly being exposed to microbes, it does not develop 
inflammation, because of both its physical and chemical barriers as well as its immune 
system. Physical barriers include the skin, mucous membranes, tears, earwax, mucus, 
and stomach acid. Usually, the skin prevents invasion from microorganisms unless it is 
damaged by an injury, insect bite, or burn. Other effective physical barriers are the 
mucous membranes, such as the linings of the mouth, nose, and eyelids. Mucous 
membranes are coated with secretions that fight against microorganisms. For example, 
the mucous membranes of the eyes are bathed in tears, which contain an enzyme called 
lysozyme that attacks bacteria and protects the eyes from infection. Enzymes and pH 
are examples of chemical barriers. Microorganisms in the air become bound to the 
mucus of the nose, which are coughed up or blown out. The digestive tract has a series 
of effective barriers, including stomach acid, pancreatic enzymes, bile, and intestinal 
secretions.  
The immune system protects the body from infection through both general and specific 
components. The innate immune system is the more general component of the immune 
system and is present even before the onset of infection. It consists of disease-resistance 
mechanisms that are not specific to particular pathogens, but induce the release of 
cellular and molecular components that recognize classes of molecules. This is because 
it either uses mechanisms or cells as well as molecules that become active within 
minutes of exposure to microbial pathogens such as gram-negative organisms (e.g. 
Escherichia coli, (lipopolysaccharide=LPS), and Pseudomonas aeruginosa) or gram-
positive organisms (e.g. lipoteichoic acid, Streptococcus pneumoniae), as well as fungal 
(e.g. Aspergillus fumigates), viral, and parasitic components. However, the immune 
system reacts against these pathogens only after recognition of pathogen components by 
innate receptors that are expressed on immune and non-immune cells. TLRs (Toll-like 
receptors), RLRs [RIG-I (retinoic acid-inducible gene-I)-like receptors], NLRs (Nod-
like receptors) and C-type lectin receptors are specific to the innate immune response. 
These so called “innate pattern recognition receptors” (PRRs) are able to identify 
pathogens or their activated products in different cellular parts, such as the plasma 
membrane or the cytoplasm. Toll-like receptor 2 (TLR2) recognizes lipoteichoic acid 
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from gram-positive bacteria and toll-like receptor 4 (TLR4) lipopolysaccharide (LPS) 
from gram-negative germs, which is thought to be an important trigger of the 
inflammatory response in sepsis. Next come the macrophages and dendritic cells, which 
phagocytize the pathogen, or induce the expression of cytokines, chemokines and co-
stimulatory molecules. Non-immune cells such as epithelial cells, endothelial cells, and 
fibroblasts also contribute to the innate immune system.  
Innate responses trigger the activation of long-lasting pathogen-specific adaptive 
immune responses. Adaptive immunity is capable of recognizing and selectively 
eliminating specific foreign microorganisms and molecules. Adaptive immune 
responses are not the same in all members of a species. Adaptive immunity is 
determined by the unique set of reactions to specific antigenic challenges that the 
organism has incurred over its lifetime. Adaptive immunity therefore has four 
characteristic attributes: antigenic specificity, diversity, immunologic memory, self/non-
self recognition. 
B- and T-cells belong to the adaptive immune system, and both arise in the bone 
marrow. B-cells produce pathogen-specific antibodies which eliminate the toxin. They 
are divided into memory B cells and effector B cells called plasma cells. Memory B 
cells express the same membrane-bound antibody as their parent B cell. Plasma cells 
produce the antibody in a form that can be secreted and have little or no membrane-
bound antibody. Although plasma cells live for only a few days, they secrete enormous 
amounts of antibody during this time. Secreted antibodies are the major effector 
molecules of humoral immunity. T-cell receptors can recognize only antigens that are 
bound to cell-membrane proteins which make up the major histocompatibility complex 
(MHC) molecules. There are subpopulations of T cells: T helper (TH) and T cytotoxic 
(TC) cells and T suppressor (TS) cell. After a TH cell recognizes and interacts with an 
antigen–MHC complex, the cell is activated and becomes an effector cell that secretes 
various growth factors known as cytokines. The secreted cytokines play an important 
role in activating B cells, TC cells, macrophages, and various other cells that participate 
in the immune response (Kindt, Osborne et al. 2000; Rittirsch, Flierl et al. 2008; Kumar, 
Kawai et al. 2009; Takeuchi and Akira 2010) (Figure 1). 
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Figure 1. Immune system response to pathogenic germs. TLRs Toll-like receptors, RLRs [RIG-I (retinoic 
acid-inducible gene-I)-like receptors], NLRs (Nod-like receptors) and C-type lectin receptors (Modified 
from Kindt, Osborne et.al. 2000). 
 
Cytokines play an important role in the pathogenesis of sepsis, because of their 
regulatory impact on cell death of inflamed tissues, modification of vascular endothelial 
permeability, and the recruiting of blood cells to the site of inflammation. Leukocytes, 
endothelial cells and other immune cells synthesize cytokines. They are a group of 
polypeptide hormones, which affect different target cells and are part of a complex 
network. Nuclear factor-κB (NF-κB) regulates the expression of cytokines and is 
involved in the immune response through T-cell and B-cell receptors. NF-κB signaling 
leads to a production of pro-inflammatory cytokines such as tumor necrosis factor α 
(TNF-α) and interleukin 6 (IL-6). During early sepsis, a hyper-inflammatory reaction 
comprised of the release of TNF-α, IL-6 and interferon ǳ (IFN-ǳ), so-called immune 
stimulation, is observed. Following the hyper-inflammatory response, the body 
responds with a compensatory reaction by producing anti-inflammatory cytokines such 
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as interleukin 10 (IL-10), which then leads to a hypo-inflammatory state, or so-called 
immune paralysis. Despite the linear occurrence of the immune reaction, there is also a 
close cross talk between the innate and adaptive immune system (Seeger and Walmrath 
2005; Takeuchi and Akira 2010) (Figure 2). 
  
 
Figure 2. Hypothetical timing of immune reaction to sepsis (Modified from Seeger and Walmrath 2005). 
 
The general effect of TNF-α is based on the inhibition of lipoprotein lipase activity, 
which induces cachexia. It is responsible for induction of other cytokines such as IL-1, 
IL-6 and IL-8. In addition, it increases the adherence of granulocytes (PMN- 
polymorphonuclear leukocytes) to endothelial cells by endothelial and granulocytic 
reactions. The cells are activated and the vascular diapedesis of PMNs into surrounding 
tissues is increased. Increased TNF-levels are the reason for the occurrence of  the first 
cardinal signs of acute inflammation described by Celsus: Dolor (pain), Calor (heat), 
Rubor (redness), Tumor (swelling) and  Functio laesa (loss of function)  (Yale 
University. Dept. of the History of Science and Medicine and Yale University. Dept. of 
the History of Medicine. 1946; Tracy 2006). TNF-α sensitizes the endothelium for the 
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coagulation cascade and induces a variety of secondary inflammatory mediators such as 
prostaglandins, thromboxane, leuktriene, NO and reactive oxygen.  
IL-6 production leads to the release of acute-phase proteins by hepatocytes. Some 
authors even suggest its role as an early prognostic parameter for sepsis outcome. In 
experimentally induced sepsis models, it is possible to obtain plasma measurements of 
TNF-α and then IL-6 after initial stimulation due to the regulated release of cytokines. 
After cell come in contact with LPS, mononuclear cells release first TNF-α, which leads 
to formation, and release of IL-6 and by autocrine feedback further release of TNF-α. 
Therefore, in this case, IL-6 is responsible for the autocrine feedback of TNF-α. 
IFN-γ, or type II interferon, belongs also to the cytokine family. It is also known as the 
primary “macrophage-activating factor” and plays a greater role in the maturation and 
function of both innate immune system and adaptive immune system cells. In addition, 
IFN-γ plays a critical role in shaping the host adaptive T-cell and B-cell response. IFN-γ 
can be considered as a broad immune mediator involved in activating and directing the 
host immune response to infection. Moreover it has immunostimulatory as well as 
immunomodulatory effects. The cytokine IL-10 inhibits the release of pro-inflammatory 
cytokines from monocytes and macrophages and the formation of inducible NO 
synthase (iNOS). These effects characterize IL-10 as a potent immunosuppressive 
cytokine (Seeger and Walmrath 2005; Gamero et al. 2006).  
 
1.1.3.1.2. General aspects of nitric oxide 
 
NO is believed to play a key role in the pathophysiology of sepsis. It is derived from the 
enzymatic oxidation of L-arginine by NO synthases (NOS) family of enzymes. There 
exists three isoforms of NOS: endothelial (eNOS) and neuronal NOS (nNOS), which 
are involved in homeostasis and an inducible form (iNOS). iNOS is mainly expressed in 
inflamed areas. Endotoxin and cytokines such as TNF-α and IL-6 induce and regulate 
the synthesis of NO from endothelial cells. The resulting arterial hypotension is a 
characteristic property of NO by septic shock. Under septic conditions NO 
concentration increases substantially; 100 to 1000-fold higher than the normal 
physiological concentration. These excessive increased NO-levels overwhelm the 
compensatory vasoconstrictive mechanisms (Iadecola 1993; Linehan, Kolios et al. 
2005). 
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1.1.3.1.3. General aspects of microcirculation as a motor of sepsis organ dysfunction 
 
Since 2005 there has been growing evidence that the microcirculation plays an 
important role in sepsis related organ dysfunction. In previous studies it has been shown 
that a microcirculatory failure appears before the collapse of the systemic 
macrocirculation. For example, lactate levels increased drastically despite persistent 
blood pressure levels (Lehr et al. 2000; Rosengarten, Hecht et al. 2007). Clinically, it 
has been demonstrated that diagnosis and treatment during the early phase of sepsis; the 
first 6 to 24 hours, are relevant for determining patient prognosis. During this early 
phase, acute activation of the innate immune response occurs, otherwise known as a 
“cytokine storm” resulting in increased NO levels which are related to progressive 
microcirculatory failure (Hotchkiss, Coopersmith et al. 2009; Lundy and Trzeciak 
2009). 
Microcirculation includes the capillaries or the smallest units or segments of the 
circulatory system. Endothelial cells, smooth muscle cells, as well as the constantly 
changing pool of circulating blood cells are affected during sepsis (Figure 3). 
Exaggerated production of pro-inflammatory cytokines and the induction of more 
mediators such as NO and prostaglandins (PGEs) have been implicated in the 
endothelial activation or dysfunction, an increase in microvascular permeability, 
endothelial-leukocyte adhesion with uncontrolled cell infiltration and vasodysregulation 
resulting in peripheral vascular resistance. These vasoactive mediators cause 
inappropriate vasodilation, hypovolemia, and myocardial depression. Vasodilation 
further decreases cardiac pre-load because of diminished venous return. This causes 
changes to occur in the shape of blood cells and capillaries as well as vasoplegia and 
misdistribution of blood flow on a microvascular level, associated with tissue hypoxia. 
Due to the damage of the blood vessels endothelial cells, an increase of capillary 
permeability (capillary leakage syndrome) results, which is responsible for the 
breakdown of endothelial and epithelial barriers such as the blood brain barrier and the 
intestinal barrier as well as general tissue edema (Vincent and De Backer 2005). 
Furthermore, cytokines induce activation of leukotrienes and platelet-activating factor 
(PAF), which have both direct effects on the endothelial surface and activate the 
extrinsic pathway of coagulation and production of thrombin. If the production of PAF 
and the potent inhibitor of fibrinolysis are active, then thrombin production results in 
fibrin clots. Finally, this results in the occlusion of capillaries by microthrombi and 
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disseminated intravascular coagulation (DIC) occurs (Bolton, Young et al. 1993; 
Vervloet, Thijs et al. 1998).   
It is the complex microcirculatory processes of cytokine release, mediator cascades and 
the subsequent induction of a pro-coagulant state that leads to hypotension, inadequate 
organ perfusion, and necrotic cell death, all of which are associated with MODS 
(Multiple Organ Dysfunction Syndrome) (Lehr et al. 2000; Müller-Werdan et al. 2005).  
 
 
Figure 3. Motor of sepsis (Modified from Spronk, Zandstra et al. 2004) 
 
 
1.1.3.1.4. General aspects of hypoxia marker during systemic inflammation 
 
Defects in distributing blood to either the regional vascular beds or the microcirculation 
could be responsible for tissue hypoxia, low glucose levels, as well as high 
concentrations of lactate and reductive metabolites. Cells of the innate immune system 
must respond to these demanding conditions to maintain viability and activity. Sensing 
and coordinating responses to hypoxia is primarily facilitated by the transcription factor 
hypoxia-inducible factor (HIF). HIF-1α and HIF-2α are key regulators of the adaptive 
response to low oxygen under non-inflammatory conditions. Their role in a variety of 
pathophysiological contexts is complex and incompletely described. Despite their 
sequence homology, HIF-1α and HIF-2α have non-overlapping and sometimes even 
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opposing roles (Imtiyaz, Williams et al. 2010). Th1 and Th2 cytokines could affect HIF-
1α and HIF-2α protein levels by regulating their transcript levels. For example HIF-2α 
is expressed exclusively in M2-polarized macrophages in contrast to HIF-1α expression 
in M1 macrophages (Takeda, O'Dea et al. 2010). Under septic conditions, HIF-1α and 
HIF-2α are differently regulated. There is evidence that HIF-1α controls inflammatory 
response through its regulation of the metabolic switch to glycolysis, a switch that is 
intrinsic to myeloid cell survival and function. HIF-1α is presented as a potential target 
for modulation of inflammation independent from normoxic or hypoxic environments. 
In contrast, HIF-2α is expressed in a more tissue-restricted manner and is not affected 
by LPS in normoxic tissue, but is reduced by additional inflammatory conditions 
(Takeda, O'Dea et al. 2010). HIF-2α serves as a conservative marker and is more 
relevant for hypoxia under inflammatory conditions.  
 
1.1.3.1.5. General aspects of apoptotic marker during systemic inflammation   
 
There are two ways by which a cell dies: by damage to the cell membrane which leads 
to necrosis or by apoptosis; or programmed cell death, which leads to shrinking and 
blebbing of the intact cell membrane. For example cell disintegration or necrosis can 
occur when the microvasculature is disrupted by fibrin deposition and intravascular 
coagulopathies. By apoptosis cells are eliminated via a programmed pathway during 
morphogenesis, tissue remodeling, and the resolution of the immune response. DNA 
fragmentation, condensation of chromatin, membrane blebbing, cell shrinkage, and 
disassembly into membrane-enclosed vesicles are performed in cells undergoing 
apoptosis. Inducers of apoptosis include steroids, cytokines such as TNF-α, IL-6, heat 
shock, oxygen free radicals, NO and FasL-expressing cytotoxic T lymphocytes. 
Apoptotic cell death occurs primarily through three different pathways: the extrinsic 
death receptor pathway, intrinsic (mitochondrial) pathway and the endoplasmic 
reticulum (ER) or stress-induced pathway. Disorganisation of apoptotic cell death might 
play important role in the tissue injury during sepsis. BAX promotes apoptosis and 
belongs to the BCL-2 family which is involved in a variety of cell processes such as 
controlling the release of apoptosis-inducing factor from mitochondria during apoptosis. 
It is suggested that BAX targets organelle membranes, including mitochondria, interacts 
with many anti-apoptotic factors, and is involved in apoptosis induction by directly 
releasing cytochrome C (Oberholzer, Oberholzer et al. 2001). 
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1.1.3.2. Cerebral aspects 
1.1.3.2.1. Cerebral aspects of sepsis 
 
Sepsis-associated delirium (SAD) is the new term for “septic encephalopathy”, which 
was described in the diagnostic manual (Diagnostic and Statistical Manual (DSM-IV) 
and International Classification of Diseases (ICD 10). It is indicated as a severe global 
cerebral dysfunction. SAD is associated with endothelial activation, vascular damage, 
reduced cerebral blood flow, oxygen extraction by the brain, and disruption of the blood 
brain barrier, all of which may arise from the action of inflammatory mediators on the 
cerebrovascular endothelium, cerebral edema, brain inflammation and apoptosis. It 
results not only in nerve cell dysfunction, but also in a dysregulation of the 
microcirculation (Papadopoulos, Davies et al. 2000; Ebersoldt, Sharshar et al. 2007). 
The brain is very sensitive to insufficient blood supply as it does not contain sufficient 
oxygen and substrate storage. Its energy supply is dependent on aerobic glycolysis. A 
few seconds of decreased oxygen leads to cellular dysfunction. There are two effective 
mechanisms of the brain, which maintain its adequate cerebral blood supply: 
neurovascular coupling and cerebral autoregulation. Under physiological conditions the 
activation of nerve cells induces changes in local cerebral blood flow. The 
neurovascular coupling mechanism adapts the brains blood circulation in accordance 
with local brain activity. Cerebral autoregulation compensates for systemic blood 
pressure changes to maintain constant cerebral perfusion. Both mechanisms are based 
on a complex interplay of various mediator systems. Increased NO concentration during 
sepsis can negatively interfere with the vasoregulative mechanisms of the brain. 
However, cerebral autoregulation attenuates sepsis related changes more robustly than 
the neurovascular coupling mechanism (Rosengarten, Hecht et al. 2008). 
 
1.1.3.2.2. Neurovascular coupling mechanism 
 
Various cellular processes of neurons require energy in the form of adenosine 
triphosphate (ATP). ATP is synthesized first by glycolysis, which is an anaerobic 
process and then by oxidative glucose metabolism, which requires oxygen and produces 
a large amount of ATP. In the brain, about 90% of glucose is metabolized aerobically. 
Cerebral metabolism thus depends on a constant supply of both glucose and oxygen. A 
continuous supply of these two energy substrates is maintained by cerebral blood flow 
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(CBF), which delivers glucose and oxygen to neural tissue through a complex of blood 
vessels. The brain is very sensitive to changes in oxygen and substrate supply, and even 
small perfusion variations can result in damage of brain cells. Therefore, it is important 
that neurons are able to balance these changes as soon as possible.  
Neuronal activity induces localized changes in blood flow. There is a close relationship 
between neuronal activity and CBF, via the neurovascular coupling mechanism. This 
mechanism assures that the blood supply to the brain matches with the energy needs of 
the cells (Freeman 2008). Increased neuronal activity leads to release of intracellular 
potassium into the extracellular space resulting in activation of potassium channels, 
which causes dilation of the cerebral resistance vessels. This response is called 
“feedforward mechanism” of CBF control (Kuschinsky, Wahl et al. 1972; Kuschinsky 
1991; Rosengarten, Lutz et al. 2003). After that, the reestablishment of the original 
extra-/intracellular distribution of ions takes place. Activation of the pumps is induced 
by carrying the potassium back into the cell which results in increased metabolic 
activity and vasodilatation. Next, the release of hydrogen ions and adenosine occurs, as 
long as a mismatch between oxygen/glucose demand and CBF supply exists. CBF is 
higher while counteracting this mismatch. This results in a so-called “feedback 
mechanism”. However flow regulation is a complex process which involves mediators 
such as adenosine, NO and others.  
LDF (Laser-Doppler-Flowmetry) is a vascular-based brain imaging technique that infers 
local changes in the dynamic vasoregulative functions of the activation flow coupling. It 
has been widely used to study evoked flow response in the cerebral cortex during 
somatosensory stimulation. This technique measures flow velocity rather than flow, but 
the relative signal changes allow accurate analysis of regional blood flow. The LDF 
signal is proportional to the number of red blood cells moving in the measuring volume 
multiplied by the mean velocity of these cells, respectively representing blood cell flux. 
In this study, neurovascular coupling measurements were performed with electrodes 
attached to the right forepaw and to the LDF (Dirnagl, Kaplan et al. 1989; Rosengarten, 
Lutz et al. 2003). 
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1.1.3.2.3. Somatosensory evoked potentials  
 
Evoked potentials are the electrical signals generated by the nervous system in response 
to sensory stimuli. Somatosensory evoked potentials (SEP) consists of a series of waves 
that reflect sequential activation of peripheral nerves along the somatosensory pathways 
and induced cortical response. After stimulation of the nerve it comes to an electrical 
discharge (depolarization) of the cell, which generates an electrical impulse called an 
action potential. Brain electrical activity is recorded by a computer which analyzes the 
speed, duration, and intensity of the neural response as well as an amplifier, filter and 
computer averaging software for better representation of the data.  
SEP is known to be a sensitive parameter for early diagnosis of SAD in intensive 
medical care units. Even if the first neurological abnormalities failed, SEP provides 
sensitive index of brain dysfunction. It shows general alterations which increase parallel 
to the severity of the systemic inflammatory process. In this study, SEP and latencies 
are performed using Electroencephalography (EEG)-recording (Ohnesorge, Bischoff et 
al. 2003; Rosengarten, Hecht et al. 2007). 
 
1.2. Aim of the study  
 
Endotoxin animal models are mainly used to analyze the complexity of the circulatory 
and metabolic alterations involved in sepsis in the entire organism. Moreover it is 
important to develop a reproducible and satisfactory small animal sepsis model which 
simulates sepsis associated organ dysfunction. However in vitro experiments cannot 
reproduce the systemic inflammatory process entirely, but can make an important 
contribution in regards to the understanding of the function of different agents. Sepsis 
induction in endotoxin animal models can be performed by intravenous, intraperitoneal, 
or intratracheal administration of toxins (LPS) or live bacteria, which results in 
bacteremia. Administration of endotoxin or performance of cecal ligation and puncture 
(CLP) causes an overwhelming innate immune response, which has some similarities to 
human sepsis. In this study, sepsis was induced in rats by intravenous administration of 
5 mg/kg LPS, as this model is standardized and induces sepsis quickly (Dyson and 
Singer 2009). 
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Microcirculation may play a key role in the pathogenesis of sepsis-related organ 
dysfunction, especially in the first 6 to 24 hours after infection. Even though have been 
intensive studies in this field, the complexity of the sepsis mechanism still remains 
poorly understood and needs further investigations. Increased TNF-α production has 
been shown to be critical for the initiation of the pro-inflammatory response. Preclinical 
studies with antibodies against TNF-α have shown good effects in experimental models 
when the drugs are administered before the inflammatory challenge, but the end result 
of the inflammation response did not change (Minnich and Moldawer 2004). Another 
potential candidate for diagnosis and therapy of early sepsis was protein C as decreased 
levels were associated with an increase in mortality by patients. Limited analysis in 
humans showed that administration of activated protein C or protein C resulted in 
reversed haemostatic alterations and organ dysfunction in septic patients (Fisher and 
Yan 2000). 
Less clear are the mechanisms resulting in microcirculatory failure in the brain under 
septic conditions. In previous studies, it was shown that measurements of SEP and 
latencies via EEG as well as neurovascular coupling and resting flow velocity recording 
via LDF, could be used as early prognostic indicators of systemic inflammatory 
response. Changes in SEP are sensitive markers for diagnosis of SAD and sepsis. It was 
shown that SEP amplitudes and related evoked flow velocity responses of the 
neurovascular coupling dropped when macrocirculation was still intact (Rosengarten, 
Hecht et al. 2007). MRI-technique was used as a sensitive parameter for detection of 
early microcirculatory brain dysfunction, but there was no detection of subtle brain 
edema 3.5 hours after sepsis induction. Furthermore, neurovascular coupling 
mechanism and somatosensory evoked potentials are more reliable for detection of early 
cerebral dysfunction (Zauner, Gendo et al. 2002; Ohnesorge, Bischoff et al. 2003; 
Rosengarten, Walberer et al. 2008). 
Other studies were focused on iNOS inhibition as a possible therapy in the modulation 
of the inflammatory response. iNOS inhibitors like 1400W did not affect the immune 
response or prevent microcirculatory collapse, and also the effects on sepsis outcome 
were mostly negative by patients. That is the reason why iNOS-inhibition can not be 
recommended for clinical practice (Vromen, Arkovitz et al. 1996; Wray, Millar et al. 
1998; Lee, Lin et al. 2005). 
An ideal agent to recruit the microcirculation during sepsis would most likely be the 
stimulation of the vagus nerve. Some researchers have tried to define the mechanism of 
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efferent vagal signaling on the inflammatory response. These investigators supposed 
that acetylcholine binds to the α7 nicotinic cholinergic receptors expressed by 
macrophages and other cell types and reduced the release of pro-inflammatory 
cytokines such as TNF-α in rats (Borovikova, Ivanova et al. 2000; Tracey 2002). It was 
shown that electrical vagus nerve stimulation inhibited the acute inflammatory response 
to acute hypovolemic hemorrhagic shock (Guarini, Altavilla et al. 2003), splanchnic 
artery occlusion shock (Altavilla, Guarini et al. 2006) and intestinal inflammation 
during experimentally induced ileus (de Jonge, van der Zanden et al. 2005). It also 
diminished shock and reduced pro-inflammatory cytokines synthesis in the livers and 
hearts, obtained from animals subjected to ischemia-reperfusion injury induced by 
transient aortic occlusion (Bernik, Friedman et al. 2002), as well as reduced localized 
inflammation in the murine arthritis model (Borovikova, Ivanova et al. 2000). This 
concept of vagal inflammatory reflex was followed by many other studies, but there is 
still no exact explanation about how vagus nerve stimulation affects sepsis. 
New therapeutic approaches which counteract microcirculatory failure could represent a 
novel strategy to help optimize the inflammatory response. The impact of sepsis on 
brain microcirculation is not well defined. Using a reproducible animal model of septic 
shock, this study sought to investigate whether vagus nerve stimulation protects the 
cerebral microcirculation and neuronal functions as well as its connection to NO 
signalling. The working hypothesis of this study suggests that vagus nerve stimulation 
during septic shock may attenuate the hyper-inflammatory host response and result in 
lower iNOS-levels. We proposed that vagus nerve stimulation during sepsis would 
decrease the severity of microcirculatory failure in the brain, which is an early 
prognostic parameter of sepsis outcome. Neurovascular coupling via LDF and SEP are 
measured in rodents and collect to clinically relevant data. Investigations of the effects 
of vagus nerve stimulation on released pro- and anti- inflammatory cytokines, NO-, 
hypoxia– and apoptosis signalling in endotoxinemic rats were performed and analyzed. 
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2. MATERIALS AND METHODS 
2.1. Laboratory animals 
Adult male Sprague Dawley rats (290-320 g) were purchased from Harlan Laboratories 
(Harlan, Rossdorf, Germany). They were housed five to a cage with food and water 
available ad libitum and were maintained on a 12-hour light/dark cycle (lights on at 7 
a.m.). All procedures performed on the animals were in strict accordance with the 
National Institutes of Health Guide for Care and Use of Laboratory Animals and 
approved by the local Animal Care and Use Committee. The Institutional Review Board 
for the care of animal subjects approved the study. 
 
2.2. General preparation 
2.2.1. Overview of the experimental station 
The arrangement of the experimental instruments is shown in Figure. 4. Instruments are 
labeled accordingly. 
 
Figure 4. Experimental Instrumentation: 1. Stimulation needles, 2. Heating pad, 3. Stereotaxic frame, 4. 
Ventilator pump, 5. Amplifier 1, 6. Isofluran pump, 7. Light source, 8. Perfusor, 9. LDF, 10. 
Thermometer, 11. PC with Neurodyn Software, 12. Amplifier 2, 13. Lactate indicator, 14. Glucose 
indicator  
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2.2.2. Inhalatory anesthesia  
Rats were initially anesthetized in an isoflurane saturated box until they achieved the 
tolerance phase III of anesthesia (1-2 minutes). After that they were brought in a supine 
position over the heating pad. The head of the rat was placed into a breathing mask, 
which was connected to isoflurane ventilator system. The animals were consistently 
anesthetized with 1.5 to 3% of isoflurane in 1:1 nitrous oxide (N2O)/(O2) oxygen 
mixture, through the breathing mask. This inhalation was adapted individually 
according to the animal's constitution. After they achieved tolerance phase III, the 
interdigital reflex was checked and the surgical intervention started. Rectal body 
temperature was recorded continuously and maintained at 37°C using a feedback-
controlled heating pad.   
 
2.2.3. Cannulation of artery and vein femoralis 
The hindlimbs of the animal were fixed on the heating pad with tape. After disinfection 
of the surgical location, 1.0-1.5 cm skin incision was made in the medial inner shank to 
expose the abdominal muscles. The tissues were moved aside to reveal A.femoralis, 
V.femoralis, and N.femoralis, using a wound spreader. 
The vessels were dissected from the surrounding tissues using anatomic iris forceps. 
The distal part of the vessels was closed with a ligature. Cannulation was achieved from 
two opened ligatures: the first open ligature was placed around the proximal portions of 
the femoral artery; the second open ligature was placed around the proximal portions of 
the femoral vein. To avoid thrombosis, the catheter was filled with heparin overnight 
and flushed with saline solution just before the cannulation. 
Cannulation was performed first on the artery and than on the femoral vein. An 
Aesculap clip was placed just above the prepared open ligature so that the blood supply 
was interrupted in the cannulated field for a short time. The vessel cut was done using 
the scissor “Nachstar from Vannas” and the catheter was inserted into it, just under the 
clip. After the clip was removed, the catheter was advanced to its final position and 
fixed with the prepared proximal ligature. Cannulation of the femoral vein was 
performed similarly, by which the catheter was advanced up towards the V.cava 
inferior. To fix both catheters, a massive ligature was placed over the other ligatures, 
followed by tape fixation at the Achilles tendon. 
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2.2.4. Tracheotomy and intubation 
After cannulation the rat was prepared for tracheotomy under the following procedures: 
the neck area was disinfected with ethyl alcohol, followed by a cutaneous incision 
starting 1 to 2 cm from the breast bone extending to the mid-cranial neck, was 
performed to expose the neck muscle and salivary glands. Next, the neck muscles were 
dissected carefully in their medial part and kept apart with wound retractor. A 
preparation was done around the trachea with anatomical iris forceps in layers until it 
lay bare. An opened ligature was placed around the trachea for later fixation of the 
tracheal tube. Just before the start of the tracheotomy, anesthesia with isoflurane was 
reduced to 1% to prevent possible overdoses of anesthetics. The trachea was cut 
between the fourth and fifth cartilage rings, the trachea tube was inserted and fixed 
together with the trachea through the ligature. The breathing mask was removed. The 
trachea tube was connected immediately to the ventilator system. This moderation was 
done quickly without the animal waking up.  
After tracheotomy and intubation the respiratory rate was maintained at 60 breaths per 
minute, an inspiration time at 0.75 seconds, and the respiratory pressure volume at 700 
cc per minute by PEEP (positive end-expiratory pressure) of 4 cm of water column 
during the entire experiment. 
 
2.2.5. Injection anesthesia and muscle relaxation 
After intubation, isoflurane narcosis was discontinued and replaced by an intravenous 
application of α-chloralose/borax–anesthesia, which was administered through the 
femoral catheter set. First a stock solution of α-chloralose and borax was prepared as 
follows: 350 mg Borax and 250 mg of α-chloralose were dissolved in 10 ml 0.9% 
sodium chloride (NaCl-solution) warmed at 40°C using a magnetic stirrer bar until the 
solution was free from borax crystals. In addition this mixture was filtered in 3 ml 
syringe using a Millipore filter (Millex ® GP filter) and injected intravenously in the 
following dose: an initial dose at 60 mg/kg body weight, washout period of 60 minutes 
for each animal, followed by a supplementary dose at 30 mg/kg body weight every 
hour.  
The spontaneous breathing of the animals was paralyzed by an additional intravenous 
administration of 0.3 ml pancuronium bromide initially. Supplementary dosage of this 
muscle relaxant was given via perfusor syringe pump, whereas it was diluted in 0.9% 
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NaCl 1:10 and given 1.2 ml per hour. This infusion was used also as a volume 
compensatory therapy. During α-chloralose anesthesia, the animals were ventilated with 
a 1:1 mixture of nitrogen and oxygen. 
 
2.3. Preparation and stimulation of vagus nerve  
The vagus nerve of each side was exposed lateral of the trachea running in parallel with 
the common carotid artery in the cervical area. The right nerve was carefully dissected 
from the artery in each rat using the fine iris forceps, while the left nerve was used for 
the experiments. This preparation was done precisely without any damage of the nerve 
fibres. Whereas the nerves were kept intact in the control group (SHAM), both nerves 
were dissected in the vagotomy group (VGX). In the group with vagus nerve 
stimulation both vagus nerves were dissected and the left distal part of the nerve was 
secured in a special nerve stimulation clamp to allow electrical stimulation 
(VGX+STIM). Electrical pulses were applied with 2 mA, 0.3 ms pulse width, and 2 Hz 
repetition frequency and stimulation was performed for 10 min. Stimulation blocks 
were repeated every 45 min, starting before the application of endotoxin and continuing 
until the end of experimentation. In the groups without stimulation, no special 
treatments were undertaken during these 10 minutes. 
 
2.4. Preparation for neurovascular coupling and data valuation 
2.4.1. Preparation for neurovascular coupling 
After the preparation of the vagus nerve, the rat was turned over onto its abdomen. The 
head was fixed in a stereotaxic frame with bolts in the ear canal. In this case it is 
important not to cause a perforation of the tympanic membrane, because this could 
cause pain and disturbe the experimental measurements (Figure 5). The upper incisors 
were hitched on the frame. Afterwards the skin over the parietal bone was cut at 
approximately 1 cm from where a tunnel under the skin and above the nasal bone was 
prepared using the “Metzenbaum” scissor. An electrode was inserted subcutaneously 
into the tunnel up to the nose to neutralize the other electrode over the cortex. The 
voltage differences between the electrodes were used for measurements of the EEG and 
the resulting SEPs. 
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The tissues above the left parietal bones and the connecting periosteum were removed 
using a “Nachstar” scissor and an anatomical iris forceps so that the apex of the skull 
was exposed. The bleeding from the small vessels was interrupted by 
electrocauterization. Using a microscope, the left parietal cortex was thinned with a 
saline-cooled drill up to the layer of compacta interna until an area was reached where 
the blood vessels appeared. No damage occurred to the underlying dura mater or the 
brain. This preparation allowed transcranial LDF. 
 
 
Figure 5. Overview of the stereotactic frame 
 
The apex of the skull was exposed, and the bone over the left parietal cortex was 
thinned with a saline-cooled drill to allow transcranial LDF. The laser probe was placed 
on the thinned skull 3.5 mm lateral and 1 mm rostral to the bregma in accordance with 
the coordinates of the somatosensory cortex; a location that corresponds closely to the 
region of maximal hemodynamic response during contralateral forepaw stimulation. 
The meaning "bregma" comes from the craniometry. It describes the point at which the 
sutura coronalis (which separates the frontal from the parietal bone) and the sutura 
sagittalis (which separates the two parietal bones) meet each other. The laser-Doppler 
signal was found by 300-350 Flux blood cell velocity, which responds to the capillary 
field.  
Brain electrical activity was recorded monopolarily with an active silver chloride 
electrode placed 0.5 mm behind the laser probe and with an indifferent calomel 
electrode placed on the nasal bone. Somatosensory stimulation was achieved with 
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electrical pulses applied by small needle electrodes inserted under the skin of the right 
forepaw. The pulses consisted of rectangular bipolar pulses of 1.5 mA and a pulse width 
of 0.3 ms. The pulse repetition frequency was set at 2 Hz and stimulations were carried 
out for 30 s. Stimulation with 1.5 mA ensured the pain fibres were unaffected and 
thereby prevented changes in blood pressure. A rest of 30 s following each stimulation 
period was performed while activation rest cycles were repeated 10 times to increase 
signal to noise ratio (Figure 6). In addition, the grounding of the stereotactic frame and 
the NaCl electrode was connected to the computer for analysis. 
 
 
Figure 6. Experimental design for measurements of the neurovascular coupling. 
 
The head of the rat was turned 45° to the right with the rotating stereotactic frame and 
its body position was moved to the right about 90°. Before the electrodes were placed 
around the nerve, the cervical area was expanded using a wound retractor from “Logan 
modell Reill” for better overview. To prevent possible damage of the artery communis 
and the surrounding tissues, two cotton particles were set between the artery and the 
vagal nerve. The whole preparation took approximately 1 hour. 
 
Experimental preparation and procedures are shown schematically on Figure 7. 
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Figure 7. Illustration of the preparation period and experimental protocol together with time points of 
vagal interaction or neurofunctional measurements.  
 
2.4.2. Data evaluation  
Evoked potential amplitudes were calculated from the N1-P1-amplitude differences and 
the latency between the beginning of stimulation and the occurrence of the P1-peak was 
examined. SEPs were averaged and the resulting convolutions were described as 
follows: upward amplitudes were defined as “negative” and downward amplitudes as 
“positive”. The “positive“ peaks were marked as “P” and the “negative” peaks as “N”. 
The recording of evoked potentials on the head starts with a positive peak (P1), 
followed by a negative one (N1) and again a positive peak (P2) (Figure 8).  
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Figure 8. SEP during stimulation of the contra lateral forepaw. 60 signals were averaged throughout 30 s 
stimulation. 
 
The evoked flow velocity responses were calculated from the averaged relative flow 
velocity signals under conditions of stimulation. Figure 9 presents flow response data of 
10 stimulation cycles as well as a comparison between the increase of blood flow during 
stimulation and the resting flow. Rodents were electrically stimulated for 30s and rested 
for 30s for a period of 10 minutes. The measurements were averaged. Signals were 
recorded and amplified and SEPs were averaged using the Neurodyn acquisition 
software.  
 
 
 
Figure 9. LDF response of somatosensory cortex area during contra lateral forepaw stimulation. One 
stimulation cycle involved 30 s stimulation and 30 s at rest. 10 cycles are shown. 
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2.5. Study design 
In random order, 60 rats received intravenously 5 mg/kg body weight LPS or 0.5 ml of 
0.9% NaCl. LPS was dissolved in 0.5 ml of 0.9% NaCl and slowly administered within 
5 min intravenously. Endotoxinemic and sham groups were further divided into three 
subgroups each. In one subgroup, bilateral vagotomy (VGX) was performed without 
stimulation of the vagal nerve (LPS group: VGX LPS; non-septic group: VGX). In a 
second group, the distal part of the left vagus nerve was stimulated (LPS group: VGX 
LPS+ STIM; sham group: VGX+ STIM). In a third group, the operation of the vagus 
nerve was stopped before vagotomy (LPS group: SHAM LPS; non-septic group: 
SHAM). Each experimental group consisted of 10 animals. Experiments were 
performed up to 4.5 h after LPS/vehicle administration.  
Blood samples were obtained directly from the left ventricle of the heart before the rats 
were killed. Afterwards a heart perfusion was performed with saline so most blood was 
removed from the brain vessels for precise analyzes. For this procedure, the rat was laid 
on its back, the cranial abdominal cavity cut 3 cm distal from the xiphoid process and 
lateral parallel to the costal arch using a scissors to expose the diaphragm. With next 
incision the diaphragm which was separated from the costal arch, followed by 3-4 cm 
incisions parallel to the sternum. The costal arch was moved aside and fixed by two 
clamps to the left and to the right. The apex of the heart was fixed by forceps and 1 ml 
blood was taken direct from the left ventricle. The vena cava ending into the right 
atrium was truncated in order to drain the liquid during perfusion. A perfusion tube was 
inserted into the left ventricle and saline was flushed through the systemic circulation 
and drained from the truncated vena cava. After perfusion 1 ml KCl was injected 
intravenously. The brain was removed rapidly and stored at -80°C.  
 
2.6. Laboratory analysis 
2.6.1. Blood parameters 
The ventilation of the animals was controlled continuously throughout the entire 
experiment. The measurements of arterial blood pressure, body temperature, glucose 
and lactate as well as the blood gas parameters were also recorded continuously. The 
glucose and lactate parameters as well as the following blood gas parameters: pH, pO2, 
pCO2 and hemoglobin were determined from arterial blood samples using blood gas 
analyzer. 
Stanka Mihaylova                         Materials and Methods 
                                                                                         
 
25 
 
 
The blood samples were taken from the arterial catheter using hematocrit capillary 
tubes. For this procedure the arterial catheter was disconnected by a scissor clamp, the 
pressure transducer was removed, and the scissor clamp was opened cautiously so that a 
drop of blood could form at the end of catheter. Sticks from glucose and lactate sets 
were placed to the blood drop as well as the hematocrit capillary tube so that they filled 
with blood. Next, the artery catheter was flushed with saline to prevent possible 
formation of blood clots and the pressure transducer was connected to it. The hematocrit 
capillary tube was inserted into the blood gas analyzer for measurements. Within a 
minute, results of the glucose and lactate set were obtained. 
 
2.6.2. Polymerase chain reaction (PCR) 
2.6.2.1. RNA isolation 
Total RNA from tissue was extracted using Trizol according to the manufacturer's 
instructions. 100 mg brain tissue was applied to 1 ml Trizol and homogenized by 
Precellys24 homogenizer. Trizol lysates were kept at room temperature (RT) for 10 min 
to dissociate the RNA from histone proteins. Then 0.2 ml of chloroform was added, 
vigorously mixed for 15 sec and centrifuged at 10500 rpm for 15 minutes at 4°C. After 
that, the transparent upper layer was carefully transferred to a new tube and gently 
mixed with 0.5 ml Isopropanol. After 10 min the mixture was centrifuged at 10500 rpm 
for 10 minutes at 4°C and the RNA pellet was washed with 1 ml 75% ethanol and air 
dried. RNA was dissolved in DEPC-water and stored at -80°C. The concentration and 
quality of RNA were estimated by NanoDrop spectrophotometer. 
 
2.6.2.2. Reverse transcription-PCR (RT-PCR) 
cDNA was synthesized by a two-step RT-PCR using ImProm-II™  reverse transcription 
system according to the manufacturer’s instructions. 8 µg RNA and 2 µl Oligo(dT)15- 
Primer were incubated at 70°C for 6 min, followed by a quick chill at room temperature 
for 5 min and addition of 30 µl reaction B. The reverse transcription reactions were 
subjected to cDNA synthesis by annealing at 25°C for 5 min and incubating at 42°C for 
60 min, followed by thermal inactivation of reverse transcriptase at 70°C for 15 min. 
The cDNA was stored at -20°C. 
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Reaction A component    Volume  Final concentration 
RNA, [0.1 µg/µl ]    8 µl   0.8 µg 
Oligo(dT)15- Primer [500 µg/ml]   2 µl   25 ng 
 
Reaction B component    Volume  Final concentration 
ImProm-II™ 5X Reaction buffer   8 µl   1 X 
MgCl2, 25 mM     4 µl   2.5 mM 
dNTP mix, [10 mM]     2 µl   0.5 mM 
RNasin® ribonuclease inhibitor   1 µl   1 U/µl 
ImProm-II™ reverse transcriptase   2 µl    
DEPC-water     13µl 
 
2.6.2.3. Quantitative real time-PCR (qRT-PCR) 
Intron-spanning primer pairs were designed using the Primer 3 program and are shown 
below. Primers were cross-checked to insure the specificity by blasting to the whole 
genome. The product size is controlled within the range of 80 bp-150 bp. 
 
qRT-PCR reaction component   Volume  Final concentration 
cDNA  0.25µg/µl    2 µl   0.5 µg 
MgCl2, 50 mM     1 µl   5 mM 
ROX, 25 µM       0.1 µl   0.1 µM 
Upstream primer, 10 µM    0.5 µl   0.2 µM 
Downstream primer, 10 µM    0.5 µl   0.2 µM 
Platinum ®SYBR® GreenER™ SuperMix 
Universal buffer     12.5 µl  1 X 
DEPC-water     8.4 µl 
 
qRT-PCR was performed on a Mx3000P® QPCR system machine using SYBR® 
GreenER™ qPCR SuperMixes Universal kits according to manufacturer’s instructions. 
For the negative control, cDNA was omitted. The annealing temperature for every gene 
was 58°C. By using the MxPro™ QPCR software, a dissociation curve was generated 
for each gene to ensure single product amplification and the threshold cycle (Ct values) 
for each gene was determined. The comparative 2-∆∆Ct method was used to analyze 
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mRNA fold changes between SHAM and LPS-treated groups, which was calculated as 
Ratio = 2-(∆Ct control-∆Ct MCT) where Ct is the cycle threshold, and ∆Ct (Ct target－Ct 
reference) is the Ct value normalized to the reference gene Porphobilinogen Deaminase 
(PBGD) obtained for the same cDNA sample. Each reaction was run in duplicate and 
repeated three times independently. The calculated 2-∆∆Ct was transformed into a 
percentage using the control as 100% to show the mRNA expression difference. 
 
qRT-PCR programm       Temperature  Time           Cycle 
Activation     95°C    10 min   1 
Denaturation     95°C    30 sec      40 
Annealing     58°C    30 sec    40 
Extension     72°C    30 sec      40 
Denaturation     95°C    1 min 
Dissociation curve    55-95°C   indefinite     1 
Soak      4°C   indefinite       1 
 
Primers for qRT-PCR: 
Rat porphobilinogen deaminase PBGD: 
Forward  5'-CAAGGTTTTCAGCATCGCTACCA-3'  
Reverse  5'-ATGTCCGGTAACGGCGGC-3' 
Rat inducible nitric oxide synthase iNOS: 
Forward  5'-CAGCCACCTTGGTGAGGGGA-3'    
Reverse  5'- TCCAGGGGCAAGCCATGTCT-3' 
Rat Bcl-2-associated X protein BAX: 
Forward  5'-CAAGAAGCTGAGCGAGTGTCT -3'   
Reverse  5'-CAATCATCCTCTGCAGCTCCATATT-3' 
 
2.6.3. Western blotting 
2.6.3.1. Protein isolation 
Total protein was extracted in RIPA buffer containing 1x TBS, 1% Nonidet P-40, 0.5% 
sodium deoxycholate, 0.1% SDS, 0.004% sodium azide. PMSF, proteinase inhibitor 
cocktail and sodium orthovanadate (10 µl each in 1 ml RIPA) were added to RIPA 
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freshly before use. 100 mg brain tissue homogenized in 800 µl RIPA was centrifuged 
under 12000 rpm for 30 min at 4°C and the supernatants were stored at -80°C. 
 
2.6.3.2. Protein concentration analysis 
A series of bovine serum albumin (BSA) solution from 0.25-2 µg/µl were used as 
standard. The protein samples were pre-diluted into the range of the standard and the 
concentration of each sample was double estimated by Dc protein assay kit based on the 
Bradford method using a microplate reader. 
 
2.6.3.3. SDS-polyacrylamide (SDS-PAGE) gel electrophoresis 
Protein samples of the same concentration were mixed with 5x SDS gel loading buffer 
at a ratio of 4:1 (v/v) and denatured at 100°C for 5 min. Protein samples or rainbow 
markers were loaded into the wells of 10% SDS-PAGE gels and ran at 100-130 V for 2-
3 hours of separation. Buffers are listed as follows. 
 
5×SDS gel-loading buffer component     Final concentration 
Tris-Cl (2 M, pH 6.8)       375 mM 
SDS          10% (w/v) 
Glycerol         50% (v/v) 
β-Mercaptoethanol        12.5% (v/v) 
Bromophenol blue        0.02% (w/v) 
Running buffer component      Final concentration 
Tris-HCl         25 mM 
Glycine         192 mM 
SDS 10% (w/v)        0.1% (w/v) 
 
Separating gel (10%) component    Volume  Final concentration 
Tris-Cl (1.5 M, pH 8.9)     1.5 ml   375 mM 
Acrylamid 30% (w/v)     2 ml   10% (w/v) 
SDS 10% (w/v)      60 µl   0.1% (w/v) 
APS 10% (w/v)      30 µl   0.05% (w/v) 
TEMED       6 µl   0.1% 
H2O        2.4 ml 
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Stacking gel (6%) component    Volume  Final concentration 
Tris-Cl (0.5 M, pH 6.8)     625µl   125 mM 
Acrylamid 30% (w/v)     500µl   10% (w/v) 
SDS 10% (w/v)      25 µl   0.1% (w/v) 
APS 10% (w/v)      12.5 µl  0.05% (w/v) 
TEMED       2.5 µl   0.1% 
H2O        1.34 ml 
 
2.6.4. Measurement of NO concentration in plasma samples 
NO metabolites including nitrite and nitrate were determined for the sepsis groups and 
for the non-LPS control group (SHAM) in n=10 plasma samples each by NOASievers 
280 according to manufacturer’s instructions. The principle of NO measurement 
depends on the reduction of nitrite and nitrate by vanadium chloride in hydrochloric 
acid at 95°C to NO gas which is given to the Nitric Oxide-analyzer connected to a 
computer for data transfer and analysis by using “NoaWin 32” software. 
For this measurement the plasma samples containing high concentrations of protein 
were deproteinized prior to analysis via cold ethanol precipitation. Contamination from 
nitrite or nitrate could occur during this procedure, especially if the reagents were 
contaminated. For this reason a blank was included to check for contamination.  
An antifoaming 204 agent; a mixture of non-silicone organic defoamers in a polyol 
dispersion 100 µl, was added to the vessel containing vanadium chloride solution at the 
beginning of the experiment. To prevent damage to the NOA from hydrochloride acid 
vapour, a gas bubbler filled with aqueous sodium hydroxide was installed between the 
purge vessel and the NOA. A standard solution of 100 mM sodium nitrite was prepared 
and dilutions of the standard were used for constructing the calibration curve. NO 
concentration was determined from the peak, which appears about 30 seconds after 
injection of the sample. All samples were measured in triplicates. 
 
2.6.5. Enzyme-linked immunosorbent assay (ELISA) 
Following the experiments, blood samples were drawn into tubes containing Heparin-
sodium 2500 (Ratiopharm, Ulm, Germany). They were immediately centrifuged and 
separated, and the plasma was stored at -80°C until analysis. Concentrations of 
cytokines including IFN-γ, TNF-α, IL-6, IL-10 in plasma samples were determined by 
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ELISA kits (BD Bioscience, Heidelberg, Germany) for each LPS group (n=6) as well as 
for the SHAM group. 
 
2.7. Statistic 
Statistical evaluation of all data was performed with ANOVA to assess differences 
between the groups. In cases of significance, a Sheffè post-hoc test was applied. If the 
assumptions of normal distribution and equality of variances could not be assured in the 
statistic F-test, a nonparametric Paired-Sign or Kolmogorov-Smirnov test was 
conducted (Statview, SAS, USA). The significance level was set to p<0.05. 
 
2.8. Substances and Instruments 
Table 1 lists all materials used for the experimental and laboratory analysis. In Figure 
10 all instruments used in the experiment are listed. 
 
 
Figure 10. Instruments used for surgery interventions: 1. Nachstar scissor from Vanna; 2. Metzenbaum 
scissor; 3. Aesculap clip;  4. Anatomic scissor; 5. Fine scissor;  6,7,8. Anatomic iris forceps; 9. Forceps 
for the clip 
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Table1. Materials 
Material Company Unit Address of the company 
Isofluran Baxter 250 ml Baxter Deutschland GmbH, 85716 
Unterschleißheim  
Gas mixture Nitrogen 5.0, 
Oxigen 5.0 
100 l Air Liquide 
Isotone NaCl DeltaSelect GmbH 100 ml DeltaSelect GmbH  
72793 Pfullingen  
Kaliumchlorid 7,45% (coloured) BiBraun 
Melsungen AG 
100 ml B.Braun Melsungen 
AG 34209 Melsungen  
Heparin-Natrium 2500 Ratiopharm 5x5 ml Ratiopharm GmbH  
89070 Ulm  
Chloralose,α-Chloralose Sigma-Aldrich 100 g Sigma -Aldrich  
Chemie GmbH 89555 Steinheim  
Borax,Natriumtetraborate 99% Sigma-Aldrich 100 g Sigma -Aldrich  
Chemie GmbH 89555  
Steinheim  
Pancuronium 
Inresa,Pancuroniumbromid 
Inresa 10x2 ml Inresa GmbH  
79114 Freiburg  
Lipopolysaccharid E.coli,  
O111:B4, L2630, LOT  
115K4092  
Sigma-Aldrich 400 mg Sigma -Aldrich  
Chemie 82024  
Taufkirchen  
Trachea tube BD Microlance shorted to 1.5 cm Becton Dickinson,Germany 
Arterenol®1ml  
Norepinephrinhydro chlorid  
Aventis 1 ml Aventis Pharma  
Deutschland GmbH  
65926 Frankfurt am Main  
Softasept®N  BiBraun 
Melsungen AG 
250 ml B.Braun Melsungen 
AG 34209 Melsungen  
Haematokrit -capillary  
Na-Heparin  
Hirschmann 
Laborgeräte  
10x100 articles Hirschmann Laborgeräte  
GmbH&Co.Kg 74246 Eberstadt  
Syringe Inject-F BiBraun 
Melsungen AG 
1 ml, 2 ml, 4 ml, 
10 ml, 20 ml 
B.Braun Melsungen 
AG 34209 Melsungen  
Original -Perfusor® Syringe OPS  
 
 
BiBraun 
Melsungen AG 
50 ml B.Braun Melsungen 
AG 34209 Melsungen  
Original -Perfusor® Charge OPS  
 
 
BiBraun 
Melsungen AG 
150 cm B.Braun Melsungen 
AG 34209 Melsungen  
Combitrans Set  
Mod.II Uni Gießen  
 
BiBraun 
Melsungen AG 
 
 
  B.Braun Melsungen 
AG 34209 Melsungen  
Stanka Mihaylova                         Materials and Methods 
                                                                                         
 
32 
 
 
Material Company Unit Address of the company 
Polyethylene Tubing Portex®Fine Bore  
Polythene Tubing 
30m,0.58mm 
ID,0.96mm OD  
  Smith Medical ASD,  
Inc.Keene, USA  
Water bath Haake 83  Haake 83 DC 30  Thermo Haake GmbH  
Dieselstr. 4,D -76227 Karlsruhe  
Isofluran pump Dräger ARDB -0715  Dräger Safety AG & Co. KGaA  
Revalstraße 1, 23560 Luebeck  
Perfusor®VI  BiBraun 
Melsungen AG 
  B.Braun Melsungen 
AG 34209 Melsungen  
Millex®GP Filter  Millex®GP 0.22 µm Millipore Corporate  
Headquarters290 Concord Rd.  
Billerica, MA 01821 USA  
Magnetic stirrer bar IKA -Combimag 
RCT  
  IKA® Werke GmbH & Co. KG 
Janke &  
Kunkel -Str. 10, D -79219 Staufen  
Laser Flow BRL -100  BRC Bio Research  
Center Co.,Ltd  
  BRC Bio Research  
Center Co.Ltd. 4F  
Yokota Bldg. 2 -28 24  
Izumi Higashi -ku  
Nagoya 461 -0001 Japan  
Ventilator pump Dwyer USA  SAR -
830/PVentilator  
SAR -830/PVentilator  
Dwyer Instruments Inc. 
P.O. Box 373, 102  
Indiana Hwy. 212, 
Michigan City, IN, 46361 USA  
Glucometer Bayer Health care  Glucometer elite 
XL  
Bayer vital GmbH,  
51368 Leverkusen  
Ascensia®Elite Sensor  Bayer Health care  1x100 articles Bayer vital GmbH,  
51368 Leverkusen  
Lactate device Arkray Lactate Pro  Arkray Inc. 57 Nishi  
Aketa -Cho, Higashi Kujo, 
Minami -Ku Kyoto Japan  
Lactate Pro®Test Strip  Arkray 1x25 articles Arkray Inc. 57 Nishi  
Aketa -Cho, Higashi Kujo, 
Minami -Ku Kyoto Japan  
Blood gas analyzer,Rapidlab™ 348  Bayer Health care    Bayer vital GmbH,  
51368 Leverkusen  
Thermostate 
 
 
Alfos PT 100  Alfos AG, 4105 Biel-Benken  
Electrocautery Aaron Aaron 900,  Aaron Medical 7100  
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Material Company Unit Address of the company 
 
 
 
High Frequency 
Desiccator  
30th Avenue N. St.  
Petersburg, FL 33710  
Dremel®  Dremel Europe  Dremel Moto -
flex  
250 Watt 22.000 
rounds 
Dremel Europe  
Kortijnenberg 60 Breda-NL  
Lamp Olympus europe  Highlight 3100  Olympus Germany GmbH  
Wendenstr. 14 -18  
20097 Hamburg  
Surgical lamp Original Hanau    Original Hanau  
Quarzlampen GmbH  
Computer for analyzis Pentium III, 
Windows 98  
    
Amplifier 1 WPI Transbridge 4 M  World Precision Instruments  
175 Sarasota Center Boulevard  
Sarasota, FL 34240 9258  
Amplifier 2 HSE   HUGO SACHS  
ELEKTRONIK HARVARD  
APPARATUS GmbH  
Gruenstrasse 1 D 79232  
March-Hugstetten  
 
Analyzing software HSE   HUGO SACHS  
ELEKTRONIK HARVARD  
APPARATUS GmbH  
Gruenstrasse 1 D 79232  
March-Hugstetten  
 
Rat IFN-γ ELISA Set BD Biosciences 
Pharmingen 
  BD Biosciences Pharmingen 
10975 Torreyana Road 
San Diego, CA 92121 
Rat TNF ELISA Set BD Biosciences 
Pharmingen 
  BD Biosciences Pharmingen 
10975 Torreyana Road 
San Diego, CA 92121 
Rat IL 10 ELISA Set BD Biosciences 
Pharmingen 
  BD Biosciences Pharmingen 
10975 Torreyana Road 
San Diego, CA 92121 
Enhanced chemiluminescence 
(ECL) kit 
Amersham   Amersham, USA 
ImProm-II™  Reverse transcription 
System 
Promega   Promega, USA 
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Material Company Unit Address of the company 
Milk powder Roth   Roth, Germany 
N,N´-methylene-bis-Acrylamide 
solution 
Roth   Roth, Germany 
Protein rainbow markers Amersham   Amersham, USA 
RIPA buffer Santa Cruz   Santa Cruz, USA 
SDS solution,10% q/v Promega   Promega, USA 
SYBR® GreenER™ qPCR 
SuperMixes Universal kit 
    Invitrogen, USA 
Tris-HCl 0.5 M, pH 6.8     Amresco SOLON, USA 
Tris-HCl 1.5 M, pH 8.8     Amresco SOLON, USA 
Trizol Invitrogen   Invitrogen, USA 
UltraPure water     Cayman Europe, Estonia 
96-well microplate     Corning, USA 
AGFA cronex 5 medical X-ray film     AGFA, Belgium 
Film casette     Kodak, USA 
Filter tips(10,100,1000µl)     Nerbe plus, Germany 
Gel blotting paper     Whatman, USA 
Nitrocellulose membrane     Pall Corparation, USA 
Tips (10,100,1000µl)     Eppendorf, USA 
BioDoc Analyzer     Biometra, USA 
Electrophoresis chamber     Biometra, USA 
Freezer(+4°C,-20°C,-80°C)     Bosch, Germany 
PCR-thermocycler     Biometra, USA 
Shaker     Biometra, USA 
Western blot unit     Biometra, USA 
Vortex machine     VWR, Germany 
Anti foam 204 Sigma-Aldrich   Steinheim, Germany 
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Material Company Unit Address of the company 
Hydrochloric acid Merck   Merck, Darmstadt, Germany 
Sodium hydroxide 1N Merck   Merck, Darmstadt, Germany 
Sodium nitrite 
 
Sigma-Aldrich   Steinheim, Germany 
Sterile isotonic saline solution 
(0.9% NaCl) 
Braun   Braun, Melsungen, Germany 
Vanadium chloride Sigma-Aldrich   Steinheim, Germany 
Microfilter Syringes  Hamilton Bonaduz 
AG 
10 µl Hamilton Bonaduz AG, CH-7402 
Switzerland 
Nitric Oxide Analyzer (NOA) 
Sievers 280 
Foehr Medical 
Instruments  
  Foehr Medical Instruments, 
Seeheim, Germany 
NoaWin 32 Software DeMeTec   DeMeTec, Langgöns, Germany 
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3. RESULTS 
Ventilation was uninterrupted and oxygen supply was controlled, therefore, blood gas 
analysis of pO2 and pCO2 did not change significantly. pCO2 levels were constant 
around 35-40 mmHg. The data are given in the tables as follows: Table 3 illustrates the 
group averaged data for glucose, lactate, and pH, partial pressure of oxygen and carbon 
dioxide as well as hemoglobin content, which were obtained at baseline conditions 
(baseline) and at the end of the experiment (end). Table 2 and 4 present the group data 
for mean blood pressure together with N2-P1 potential amplitude, P1 latency, the 
evoked flow velocity response and resting LDF signal for septic and non septic animals. 
Laboratory findings are presented as followed: 
Figure 11: Data for mean arterial blood pressure (BP), SEP, evoked hemodynamic 
responses (EVFR), and resting laser-Doppler flow values (resting LDF); Figure 12: 
Cytokine concentrations of TNF-α, IFN-ǳ, IL-6, and IL-10 in plasma samples; Figure 
13: NO-signalling by qRT-PCR and western blot analysis of iNOS expression in the 
cortex; Figure 14: Western blot analysis and quantification of HIF 2 α expression in the 
cortex ; Figure 15: Real time PCR BAX mRNA expression in the cortex 4.5h after LPS 
administration for all LPS groups and the control group. 
 
3.1. Vagal effects on clinical and neurofunctional data in non-septic 
rats 
In non-endotoxinemic groups, VGX and VGX+STIM did not significantly change 
clinical or neurofunctional data as compared to the baseline. In response to stimulation 
of the left nervus vagus no significant blood pressure decrease was induced: SHAM 
116±20 mmHg vs. 108±20 mmHg; VGX 115±13 mmHg vs. 115±22 mmHg; 
VGX+STIM 109±10 mmHg vs. 93±21 mmHg (Table 2). 
pH level was higher than the physiological level. The higher pH across all experimental 
groups was related to the α-chloralose anaesthesia which leads to a well-known 
metabolic alkalosis effect: SHAM 7.49±0.06 vs. 7.47±0.03; VGX 7.45±0.05 vs. 
7.50±0.06; VGX+STIM 7.52±0.06 vs. 7.51±0.04. Similar to the SHAM group and due 
to the volume administration, hemoglobin levels decreased moderately until the end of 
experiments in each group (VGX 140±10 g/l vs. 130±10 g/l and VGX+STIM 130±10 
g/l vs. 100±20 g/l, respectively, both p<0.05; Table 3). 
Stanka Mihaylova                           Results 
                                                                                         
 
37 
 
 
Glucose levels were stable throughout the experiment (SHAM 63±8 mg/dl vs. 84±21 
mg/dl; VGX 98±30 mg/dl vs. 98±18 mg/dl; VGX+STIM 71±15 mg/dl vs. 105±49 
mg/dl, Table 3) as well as lactate levels (SHAM 0.8±0.05 mmol/l vs. 0.9±0.1; VGX 
0.8±0.03 mmol/l vs. 0.9±0.1; VGX+STIM 0.9±0.2 mmol/l vs. 1.3±0.5, Table 3).  
Baseline 30min 60min 120min 180min 240min 270min 
Mean BP 
(mmHg) SHAM 116±20 120±12 108±20 113±14 114±19 108±20 108±20 
Mean BP 
(mmHg) VGX 115±13 110±13 112±19 109±14 110±17 115±22 115±22 
Mean BP 
(mmHg) VGX+STIM 109±10 99±14 103±18 100±23 104±29 93±21 93±21 
SEP (µV) SHAM 13±7 15±6 14±4 15±5 14±5 15±5 14±5 
SEP (µV) VGX 15±9 15±8 16±9 16±9 15±6 15±6 16±8 
SEP (µV) VGX+STIM 15±9 13±4 14±4 12±5 11±5 13±3 15±8 
P1 latency (ms) SHAM 10,8±1 11,1±1 11,2±1 11,1±1 11,3±1 11,4±1 11,7±2 
P1 latency (ms) VGX 10±0,6 10±0,5 10±0,6 10±0,4 10±0,4 10±0,4 10,1±0,5 
P1 latency (ms) VGX+STIM 10,2±1 10,4±1 10,5±1 10,3±1 10±0,7 10±0,7 10±0,9 
EFVR (%) SHAM 34±10 26±7 30±11 31±15 29±14 31±12 28±7 
EFVR (%) VGX 23±13 23±15 21±11 24±15 24±6 23±7 24±11 
EFVR (%) VGX+STIM 33±13 35±18 36±13 29±17 31±18 32±25 38±14 
Resting LDF (U) SHAM 163±66 152±71 140±62 145±82 142±75 145±71 139±72 
Resting LDF (U) VGX 233±78 219±106 211±88 199±84 203±101 213±111 201±107 
Resting LDF (U) VGX+STIM 224±92 231±75 232±60 239±30 193±33 196±49 186±57 
Table 2: Group averaged data for mean blood pressure, somatosensory evoked potentials, P1 latencies, 
evoked flow velocity responses and resting LDF signal at the different time points of the experiment. 
Data are given as the mean ± standard deviation (SD) together with statistical differences. BP=blood 
pressure; EFVR=evoked flow velocity responses; LDF=Laser-Doppler flowmetry; SEP=somatosensory 
evoked potentials; SHAM=sham surgery; VGX=bilateral vagotomy; VGX+STIM=bilateral vagotomy 
and distal vagus nerve stimulation. 
 
Evoked flow velocity responses were reduced slightly but not significantly only in 
SHAM group compared to baseline (34±10% vs. 28±7%, Table 2). There were no signs 
of cerebral hyperaemia in these groups, too. SEP remained the same in the non-
endotoxinemic groups as well as the P1 latency, which stayed around 10-11 µV (Table 
2). 
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ph
Base End Base End Base End Base End Base End Base End
SHAM 63±8 84±21 0,8±0,05 0,9±0,1 7,49±0,06 7,47±0,03 250±18 246±29 36±3 38±4 140±10 120±20**
VGX 98±30 98±18 0,8±0,03 0,9±0,1 7,45±0,05 7,50±0,06 265±19 250±23 41±8 33±4 140±10 130±10*
VGX+STIM 71±15 105±49 0,9±0,2 1,3±0,5 7,52±0,06 7,51±0,04 259±19 248±5 37±5 36±5 130±10 100±20*
SHAM LPS 65±13 69±26 0,8±0,1 1,9±0,5ɫ 7,47±0,05 7,45±0,03 250±14 233±30 40±4 35±3* 150±10 120±10ɫ
VGX LPS 82±22 129±90 0,8±0,1 2,2±0,7ɫ 7,45±0,07 7,37±0,08** 272±13 249±26 41±6 39±4 150±10 120±20**
LPS+STIM 85±25 65±20 0,9±0,1 1,8±0,6*** 7,48±0,4 7,43±0,1 251±22 233±21 38±2 35±5 130±10 100±20***
Glucose (mg/dL)Lactate (mmol/L) p02(mmHg) pC02 (mmHg) Hemoglobin(g/l)
 
Table 3: Group averaged data for glucose, lactate, pH, p02, pC02 and hemoglobin. Data are given as the 
mean± standard deviation (SD) together with statistical differences. Significance is given as: * p<0.05; ** 
p<0.01; *** p<0.001; S p<0.0001 compared with baseline. pC02=partial pressure of carbon dioxide; 
SHAM=sham surgery; LPS=lipopolysaccharide; VGX=bilateral vagotomy; VGX+STIM=bilateral 
vagotomy and distal vagus nerve stimulation. 
3.2. LPS effects on clinical and neurofunctional data in non treated 
endotoxinemic rats 
No rats died from 5 mg/kg LPS injection during the experiment, because it was injected 
slowly within 5 minutes, which prevented anaphylactic shock. Compared to the control 
animals, LPS-treated animals developed signs of a moderate sepsis-like syndrome with 
typical changes in blood pressure (SHAM LPS: baseline 123±11 mmHg vs. 90±18 
mmHg, p<0.0001, Table 4), occurrence of metabolic acidosis by pH-level (SHAM LPS: 
baseline 7.47±0.05 vs. 7.45±0.03, Table 3), increase of lactate concentrations (SHAM 
LPS: baseline 0.8±0.1 mmol/l vs. 1.9±0.5 mmol/l, p<0.0001, Table 3). Hemoglobin 
levels dropped similarly from 150±10 g/l to 120±10 g/l, p<0.0001.  
Neurological parameters tended to decline in function during sepsis as well. The evoked 
flow responses declined to 12±8%, which made 15% difference from the baseline 
(EFVR 27±11% vs. 12±8%, p<0.05, Table 4). Similarly SEP fell from 17±5 µV to 10±6 
µV, p<0.01 (Table 4). In addition P1 latency showed a levelling off at 10 ms. 
3.3. Vagal effects on clinical and neurofunctional data in VGX and 
VGX+STIM endotoxinemic rats 
All vagotomized and vagus nerve stimulated rats survived injection of 5 mg/kg LPS. 
They also developed signs of a moderate sepsis-like syndrome with typical changes in 
blood pressure (VGX LPS: baseline 117±9 mmHg vs. 97±10 mmHg, p<0.01; VGX 
LPS+STIM: baseline 119±13 mmHg vs. 90±14 mmHg, p<0.001, Table 4, Figure 11A). 
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Compared to the SHAM LPS group, lactate levels of VGX LPS-group rose significantly 
to 2.2±0.7 mmol/l (p<0.0001), what was more than the stimulated group (VGX 
LPS+STIM 1.8±0.6 mmol/l, p<0.001). In vagotomised animals, a considerable 
occurrence of metabolic acidosis was observed at the end of the experiment, which was 
significant compared to baseline (pH: 7.45±0.07 vs. 7.37±0.08, p<0.01, Table 3). 
Hemoglobin values were increased in both groups as well (VGX LPS: baseline 150±10 
g/l vs. 120±20 g/l, p<0.01; VGX LPS+STIM: baseline 130±10 g/l vs.100±20 g/l, 
p<0.001). 
EFVR and SEP declined by the VGX group and remained stable in the VGX+STIM 
group. 
Baseline 30min 60min 120min 180min 240min 270min 
Mean BP 
(mmHg) SHAM 116±20 120±12 108±20 113±14 114±19 108±20 108±20 
Mean BP 
(mmHg) SHAM LPS 123±11 118±14 106±15** 104±10** 90±12ɫ 90±18ɫ 90±18ɫ 
Mean BP 
(mmHg) VGX LPS 117±9 109±17 91±17ɫ 94±18*** 101±13* 97±10** 97±10** 
Mean BP 
(mmHg) 
VGX 
LPS+STIM 119±13 114±12 94±17* 92±7*** 86±20ɫ 90±14*** 90±14*** 
SEP (µV) SHAM 13±7 15±6 14±4 15±5 14±5 15±5 14±5 
SEP (µV) SHAM LPS 17±5 16±6 15±6 12±6* 11±5* 11±4** 10±6** 
SEP (µV) VGX LPS 18±6 15±4 14±5 12±4** 11±7** 10±5** 8±5*** 
SEP (µV) 
VGX 
LPS+STIM 18±8 18±9 19±9 16±5 16±5 14±4 15±7 
P1 latency (ms) SHAM 10,8±1 11,1±1 11,2±1 11,1±1 11,3±1 11,4±1 11,7±2 
P1 latency (ms) SHAM LPS 10±0,5 10±0,6 10±0,5 10±0,6 10±0,6 10,3±0,7 10,4±1 
P1 latency (ms) VGX LPS 10±0,8 10,4±1 10,4±0,8 10,6±0,4 10,6±0,7 11±0,9 11±1 
P1 latency (ms) 
VGX 
LPS+STIM 10±0,4 10±0,3 10±0,3 10±0,3 10±0,4 10,2±0,4 10±0,4 
EFVR (%) SHAM 34±10 26±7 30±11 31±15 29±14 31±12 28±7 
EFVR (%) SHAM LPS 27±11 29±11 26±8 18±10 18±16 14±11* 12±8* 
EFVR (%) VGX LPS 34±9 36±7 26±5 19±9** 17±16** 7±5ɫ 7±4ɫ 
EFVR (%) 
VGX 
LPS+STIM 34±8 35±11 32±9 31±13 28±12 29±13 28±13 
Resting LDF (U) SHAM 163±66 152±71 140±62 145±82 142±75 145±71 139±72 
Resting LDF (U) SHAM LPS 202±56 198±64 186±64 189±72 204±96 215±104 250±105 
Resting LDF (U) VGX LPS 160±70 141±58 151±62 157±57 192±60 198±67 196±59 
Resting LDF (U) 
VGX 
LPS+STIM 173±68 165±69 177±69 185±65 227±35 231±56 227±52 
Table 4: Group averaged data for mean blood pressure, somatosensory evoked potentials, P1 latencies, 
evoked flow velocity responses and resting LDF signal at the different time points of the experiment. 
Data are given as the mean ± standard deviation (SD) together with statistical significances. Significance 
is given as: * p<0.05; ** p<0.01; *** p<0.001; S p <0.0001 compared to baseline. Data are given as the 
mean± standard deviation (SD) together with statistical significances. 
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3.4. Comparison of therapy regimes 
The inflammatory response tended to be mitigated in the stimulated group (VGX 
LPS+STIM) whereas an opposite effect was noted in the vagotomised one (VGX LPS). 
Both vagal interventions did not have a significant effect on changes in the mean 
arterial blood pressure (mean BP, Figure 11A) or resting LDF (Figure 11D). However, 
SEP amplitudes (SEP, Figure 11B) and evoked flow velocity responses (EFVR, Figure 
11C) were stabilized under vagal stimulation while an opposite effect was seen in the 
vagotomised group (Table 4). In the SHAM LPS group, EFVR significantly declined 
240 min after LPS application with the smallest responses at the end of the experiments 
(SHAM LPS: 4.5 h: 12±8% vs. baseline: 27±11%, p=0.05, Table 4). On the one hand a 
stronger and earlier (120 min) lowering of EFVR was seen in the vagotomised group 
(VGX LPS: 4.5 h: 7±4% vs. 34±9%, p<0.0001, Table 4). On the other hand stimulated 
group stabilized hemodynamic responses throughout the study (VGX LPS+STIM: 4.5 
h: 28±13% vs. 34±8%, p=n.s.). Similarly, the same group stabilized evoked potential 
amplitudes under inflammatory conditions (VGX LPS+STIM: 4.5 h: 15±7 µV vs. 
baseline: 18±8 µV, p=n.s., Table 4) whereas the SHAM LPS group showed a significant 
decline (SHAM LPS: 4.5h: 10±6 µV vs. baseline: 17±5 µV, p<0.01, Table 4). The first 
significant drop compared to the baseline occurred 240 min after LPS application in the 
SHAM LPS group (Table 4). Again, the vagotomised group showed a stronger and 
earlier (120 min) significant decline in potential amplitudes (VGX LPS: 8±5 µV vs. 
18±6 µV, p<0,001, Table 4). The P1 latencies did not differ with time or between 
groups (Table 4). The occurrence of cerebral hyperaemia as concluded from the resting 
flow velocity recordings was approximately 30% among all endotoxinemic groups 
(Figure 11D, Table 4). In contrast to the non-septic rats cerebral blood flow increased 
gradually after sepsis induction. While systemic hypotension occurred in the 
endotoxinemic groups there was a considerable increase of the cerebral blood flow 
(Figure 11D) and drop of the evoked blood flow (SHAM LPS and VGX LPS). 
Comparing the VGX LPS and VGX LPS+STIM group at each time point, there was a 
significant difference in the EFVR after 180 min, whereas the SEP amplitudes first 
differed at 4.5 h. These data indicate that uncoupling precedes changes in evoked 
potentials. Similarly, comparing the VGX LPS+STIM and the SHAM LPS groups a 
significant decline in EFVR in the SHAM LPS group occurred at 4.5 h, while the 
potential amplitudes did not differ between the groups at this time point.  
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Figure 11: Data for mean arterial blood pressure (BP, (A)), somatosensory evoked potential amplitudes 
(SEP, (B)), evoked hemodynamic responses (EVFR, (C)), and resting laser-Doppler flow values (resting 
LDF, (D)) are given for the LPS treated groups. There were no significant differences for the BP and 
resting LDF between the groups. The resting LDF increased approximately 30% until the end of 
experiments. Vagus nerve stimulation stabilized potential amplitudes (VGX LPS+STIM; * p<0.05 vs. 
SHAM LPS, graph B) whereas vagotomy had an opposite effect (VGX LPS) as compared to the sham 
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surgeries (SHAM LPS). The evoked responses remained stable throughout the experiments in the VGX 
LPS+STIM group showing a significant difference to the SHAM LPS group (* p<0.05, VGX LPS+STIM 
vs. SHAM LPS, graph C). Again, vagotomy had a negative effect on the uncoupling (# p<0.05, VGX vs. 
VGX LPS+STIM, ## p<0.01, VGX vs. VGX LPS+STIM, graph C). n=10 rats each. Data are given as the 
mean ± SEM. 
 
3.5. Vagal effects on cytokines in septic rats  
 
 
Figure 12. Cytokine concentrations in plasma samples 4.5h after LPS administration for all LPS groups 
and the control (SHAM, white bar) group. (A) TNF-α, (B) IFN-ǳ, (C) IL-6, and (D) IL-10 levels 
measured by ELISA. In all groups a significant increase occurs under septic conditions. Although vagus 
nerve stimulation (VGX LPS+STIM; black bar) appears to have an anti-inflammatory action, while 
vagotomy (VGX, gray bar) has a pro-inflammatory action, statistical examinations between the groups 
were insignificant. Statistical differences versus SHAM are given as * p<0.05; ** p<0.01; *** p<0.001; 
n=6 rats in each group. Data are given as the mean ± SEM. 
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Compared to SHAM, TNF-α, IFN-ǳ, IL-6 and IL-10 levels in plasma samples 4.5h after 
LPS administration measured by ELISA were increased significantly under septic 
conditions. Interestingly, vagus nerve stimulation appears to have an anti-inflammatory 
action, while vagotomy has a pro-inflammatory action, however statistical examinations 
between the groups were insignificant. A trend towards decreased inflammation levels 
by vagal stimulation and increased levels in vagotomised animals was observed (Figure 
12). 
 
3.6. Vagal effects on NO signalling in septic rats  
NO signalling was analysed on mRNA and protein level from cortex tissue as well as on 
plasma level using nitrite and nitrate determination method 4.5 hours after intravenous 
LPS-injection (Figure 13). Although there were no major differences of iNOS mRNA 
expression within the LPS groups, there was a significant increase in the protein levels 
as shown by western blot analysis. The endotoxinemic groups vagotomy (VGX LPS) 
and vagus nerve stimulation (VGX LPS+STIM) showed a further significant increase in 
NO signalling as compared to SHAM LPS (# p<0.01 VGX LPS+STIM vs. SHAM LPS; 
$ p<0.001 VGX LPS+STIM vs. SHAM LPS; Figure 13B).  
Nitrite and nitrate levels rose sharply in all sepsis groups. Interestingly, they were 
significantly lower in the VGX LPS group as compared to the other two LPS groups 
(Figure 13C). 
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Figure 13. Real time PCR iNOS mRNA expression (graph A), western blot analysis, and protein 
qualification of iNOS expression (graph B) in rat cortexes 4.5h after LPS administration for all LPS 
groups and the control group (SHAM, white bar). Graph C shows the results of the plasma nitrate/nitrite 
quantification from sampels taken 4.5h after LPS administration. Besides a significant increase in the 
mRNA expression in all LPS groups (* p<0.05, ** p<0.01 vs. SHAM, graph A) there were no differences 
comparing the vagotomy (VGX LPS, gray bar), LPS-treated and sham-operated (SHAM+LPS, light gray 
bar) or vagus nerve-stimulated (VGX LPS+STIM, black bar) groups (n=6 rats). All LPS groups showed a 
significant increase in iNOS protein compared to SHAM. Within the LPS groups, vagotomy (VGX LPS, 
gray bar) and vagus nerve stimulation (VGX LPS+STIM, black bar) led to a further significiant increase 
compared to SHAM LPS (light gray bar). ** p<0.01, *** p<0.001 compared to SHAM, # p<0.01 VGX 
LPS+STIM vs. SHAM LPS, $ p<0.001 VGX LPS+STIM vs. SHAM LPS. n=3 rats each. Nitrite/nitrate 
significantly increased in all LPS groups compared to SHAM. Compared to SHAM LPS (light gray bar) 
and vagus nerve stimulation (VGX LPS+STIM) the VGX LPS (gray bar) group showed significantly 
lower values. *** p<0.001 compared to SHAM; # p <0.001 compared to SHAM. n=10 rats each. Data are 
given as the mean ± SEM. 
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3.7. Vagal effects on hypoxia- and apoptosis signalling in septic rats  
Western blot analysis and quantification of HIF-2α expression in the cortex 4.5h after 
LPS administration for all LPS groups and the control group is shown in Figure 14. 
HIF-2α was increased significantly only in the VGX LPS group as compared to the 
SHAM (p<0.05 compared to SHAM), while no significant difference was detected in 
the SHAM LPS and VGX LPS+STIM group. The significant increase in the VGX LPS 
group is an indicator of a hypoxic condition. 
Analysis of apoptosis signalling molecule BAX at mRNA level showed no differences 
between endotoxinemic groups and control SHAM group (Figure 15). 
 
 
Figure 14. Western blot analysis and quantification of HIF-2α expression in the cortex 4.5h after LPS 
administration for all LPS groups and the control group (SHAM, white bar). With the exception of the 
vagotomy group (VGX LPS, gray bar), no significant differences to the SHAM group were found in the 
LPS-treated and sham-operated (SHAM+LPS, light gray bar) or vagus nerve-stimulated groups (VGX 
LPS+STIM, black bar). The significant increase in the VGX LPS (gray bar) group is an indicator of a 
hypoxic condition; * p<0.05 compared to SHAM; n=3 rats each. Data are given as the mean±SEM. 
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Figure 15. Real time PCR BAX mRNA expression in the cortex 4.5h after LPS administration for all LPS 
groups and the control group (SHAM, white bar). Compared to SHAM LPS groups did not show any 
differences. LPS groups with vagotomy (VGX LPS, gray bar), sham operation (SHAM+LPS, light gray 
bar) or vagus nerve stimulation (VGX LPS+STIM, black bar) also did not show differences. N=6 rats 
each. Data are given as the mean±SEM. 
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4. DISCUSSION 
4.1. Sepsis-associated delirium 
Sepsis is a major cause of death in intensive care units. There is increasing evidence that 
early therapeutic intervention can play a key role in improving survival after sepsis. In 
the early phase of sepsis, two pivotal pathogenic mechanisms trigger disease 
progression: a massive stimulation of the innate immune system called the cytokine 
storm, and NO-related progressive microcirculatory failure (Hotchkiss, Coopersmith et 
al. 2009; Lundy and Trzeciak 2009). Previous studies showed that microvascular 
dysregulation occur in patients during the early stages of sepsis. The observed 
abnormalities are greatest in more severely ill patients and are thought to be involved in 
the pathogenesis of sepsis related organ dysfunction (Trzeciak, Dellinger et al. 2007; 
Spanos, Jhanji et al. 2010). It has been shown that the microcirculatory failure is 
responsible for the first cardiac, pulmonary and gastrointestinal dysfunctions and 
appears before changes in the macrocirculation (Vincent and De Backer 2005; 
Rosengarten, Hecht et al. 2007). However further efforts to improve sepsis survival 
focus increasingly on intervention during its earliest stages. 
Brain dysfunction occurs early in the course of systemic sepsis. The brain is susceptible 
to an insufficient blood supply due to strict aerobic metabolic pattering and its inability 
to store oxygen. Early uncoupling of the neurovascular coupling (NVC) was shown to 
precede changes in evoked potential amplitudes, indicating a critical role of the cerebral 
microcirculation in the occurrence of SAD (Rosengarten, Hecht et al. 2007). This has 
led to a particular emphasis on the SAD management within the first few hours of sepsis 
progress (Rivers, Nguyen et al. 2001). 
In the last years, distal vagus nerve stimulation has evolved as a promising new 
therapeutic regimen mitigating the inflammatory response and improving the outcome 
in animal models of sepsis in early and late stages (Borovikova, Ivanova et al. 2000; 
Tracey 2007). However, the effects of vagus nerve stimulation on the cerebral 
microcirculatory function in the early stage of sepsis, as well as on NO levels, had not 
been investigated. Therefore, this study was primarily concerned with the role of distal 
vagus nerve stimulation vs. vagotomy on the integrity of the NVC in the brain by using 
a rat sepsis model by endotoxin-induced inflammatory syndrome. The effects on 
cytokine production, markers of apoptosis, hypoxia and the NO-signalling are presented 
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as well as the assessment of sepsis progress. Non-specific effects of both vagal 
interventions on the NVC were assessed in non-septic rats. 
 
4.2. Vagus nerve as a modulator of inflammatory response 
The central nervous system consists of two parts: the somatic nervous system and the 
autonomic nervous system (ANS). Autonomic nervous system is responsible for 
maintaining homeostasis like arterial pressure, gastrointestinal motility and secretion, 
body temperature and other activities. It consists of peripheral and central components. 
The peripheral component consists of ganglia and nerves distributed throughout the 
body and the central of centers and nuclei located in the central nervous system (CNS). 
The peripheral nervous system (PNS) contains efferent (or motor) neurons, which 
project chiefly to, and control the activity of, smooth muscle and secretory cells, and 
afferent (or sensory) neurons, which signal to the sensory side of the system and support 
both sensation and reflexes. The efferent visceromotor neurons have three subdivisions: 
parasympathetic and sympathetic nervous system that usually act reciprocally of each 
other and the enteric nervous system, which are known as autonomic nervous system.  
About 75% of parasympathetic nerve fibers arise from the tenth cranial nerves, however 
the vagus nerves is bilateral. The vagus nerve originates in the medulla oblongata and 
travels all the way through the cervical area to the thoracic and abdominal regions of the 
body. It supplies parasympathetic innervations to the heart, the lungs, the esophagus, 
small intestine, the proximal half of the colon, the liver, the pancreas, and the ureters. It 
consists of preganglionic neurons. However, the preganglionic fibers travel 
uninterrupted to their destination and synapse with postganglionic neurons inside or 
near the target organ where short postganglionic fibers spread throughout the organ. 
The brain receives information from the immune system by humoral as well as neural 
pathways. Vagus nerves signal to the brain for danger. For example cytokines and 
bacterial products such as endotoxin stimulate afferent neural fibers, which proceed to 
the brain through the vagus nerve and result in the initiation of an acute phase response 
and induction of fever (Maier, Goehler et al. 1998). 80-90% of the nerve fibers in the 
vagus nerve are afferent (sensory) nerves communicating the state of the viscera to the 
brain. The neurotransmitter at the vagal presynaptic terminals is acetylcholine (Ach). 
Through the humoral route cytokines can signal via circumventricular organs. 
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Parasympathetic innervation of the heart is mediated by the vagus nerve. Specifically, 
the vagus nerve acts to lower the heart rate. The right vagus innervates the sinoatrial 
node. Parasympathetic hyperstimulation results in bradyarrhythmias after therapy. The 
left vagus when hyperstimulated predisposes the heart to atrioventricular (AV) blocks. 
However, the left vagus nerve has less cardio-depressive effects then the right one. 
Thus, the left vagus nerve stimulation was chosen for the current study (Berthoud 2008; 
Klabunde 2011). 
  
Anti-inflammatory cholinergic effects of vagus nerve  
In the last few years, electrical stimulation of the vagus nerve has been conceptualized 
as an alternative therapy for modulating the inflammatory response during sepsis. The 
mediator involved in this so-called “cholinergic anti-inflammatory pathway” is Ach, 
which is the neurotransmitter of sensory neurons and others. Acetylcholine putatively 
binds to the α7 nicotinic cholinergic receptors expressed by macrophages and other 
immune cell types and reduces the release of the pro-inflammatory cytokine like TNF-α. 
It is suggested that the spleen is involved in cytokine regulatory effect of vagus nerve 
stimulation. Despite intensive research and discussions about possible vagal fiber 
switching to the spleen, there is a considerable lack of evidence proving direct vagus 
nerve innervation to the spleen. Other researchers showed data that electrical vagus 
nerve stimulation inhibited the acute inflammatory response in acute hypovolemic 
hemorrhagic shock (Guarini, Altavilla et al. 2003), splanchnic artery occlusion shock 
(Altavilla, Guarini et al. 2006) and intestinal inflammation during experimentally 
induced ileus (de Jonge, van der Zanden et al. 2005). This first concept of vagal 
inflammatory reflex by Tracey and others did not clarify the exact mechanism of how 
vagal stimulation is affecting the sepsis (Borovikova, Ivanova et al. 2000; Tracey 2002; 
Rosas-Ballina and Tracey 2009).  
By cervical bilateral vagotomy the afferent input from the entire vagus nerve to the 
brain is eliminated, so that the activation of the brain is interrupted. In addition bilateral 
vagotomy worsened the inflammation by sharply increasing TNF-α levels in the liver 
(Borovikova, Ivanova et al. 2000). Other studies showed, that subdiaphragmatic 
vagotomy blocked or attenuated plenty of brain-mediated responses to peripheral 
immune organs (Maier, Goehler et al. 1998). 
Alternatively to vagal stimulation, the pharmacological stimulation of the α7 subunit of 
the nicotinic Ach receptors could be used. GTS-21 is α7nAChR-selective partial 
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agonist, which attenuated cytokine production and was investigated for treatment of 
Alzheimer´s disease. CNI-1493 similarly to GTS-21 has anti-inflammatory effect by 
inhibition of pro-inflammatory cytokines. In clinical studies, both CNI-1493 and GTS-
21 were neither of which cross the blood brain barrier, were proven to be less effective 
than vagus nerve stimulation (Zheng, Wei et al. 2007; van Westerloo 2010). 
The vagal immune effects, which moderate the inflammatory response and prevent 
tissue damage may lead to new therapeutic approaches for septic patients. The efferent 
vagal nerve is more relevant for further explorations than the afferent one, due to its 
possible direct effect on innervation of the reticuloendothelial system. Taken together, 
stimulation of efferent vagus nerve leads to robust stimulation of inflammatory 
pathways, but further investigations need to be performed to assess the overall effects. 
In conclusion, neurological recordings of SEP and NVC as well as analysis of NO 
system, cytokines, hypoxic and apoptotic modulators contribute to our understanding of 
the cholinergic anti-inflammatory mechanism. 
 
4.3. Animal model 
Different experimental models exist for the reproduction of pathophysiological 
conditions. Likewise, in vitro experiments are useful complements for animal 
experiments including: ex vivo organ culture, cell culture, which can all be performed in 
a special medium according to their physiological milieu. However, the practical 
application of data obtained from in vitro experiments concern mainly structural and 
functional connections between cells and tissues. They cannot fully replicate the 
complexity of a systemic inflammatory response.  
In contrast in vivo models are experiments implemented on living organisms which give 
researchers the opportunity to holistically analyze the complexity of the septic process. 
The clinical course of sepsis is usually prolonged, taking days to weeks to manifest as 
progressive organ failure. By contrast, the time course of illness in animal models 
ranges from hours to days, which intensifies the process of sepsis. This study was 
performed using a standardized rat animal model using established ways for 
measurements of NVC and SEP thereby making it a clinically relevant model. 
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4.4. Endotoxin/LPS animal model  
This study presents pathophysiological changes similar to the sepsis associated 
inflammatory response in humans via an endotoxin animal model. Endotoxin models 
are easy to perform and relatively easy to replicate. The endotoxin animal model used in 
this study was already standardized for examination of neurovascular measurements 
occurring during sepsis (Rosengarten, Hecht et al. 2007). Administration of endotoxin 
to rats results in hemodynamic and biochemical abnormalities, which are like those 
observed during severe sepsis in humans. Endotoxin is an essential ingredient of the 
outer cell wall of gram-negative bacteria which initiates innate immune defense by 
activation of toll-like receptor-4 (TLR-4). TLR-4 cell signaling results in the 
transcription of inflammatory genes. Often used sepsis models are the exogenous 
administration of LPS intravenously, intraperitoneally, intratracheally or by CLP. In this 
model is used intravenous administration of 5 mg/kg LPS which replicates septicaemia. 
Higher doses of LPS trigger a more pronounced sepsis-like syndrome. Intravenous LPS 
administration can be tightly controlled with precise dosage of the endotoxin and assure 
fast activation of host response. On the contrary, CLP induces polymicrobic sepsis in 
which exactly dose can not be controlled, because it is not known exactly how many 
microorganisms are passing through the puncture. Here, the limitation lies in the exact 
timing of the abdominal translocation of the pathogen germs. For this reason, 
intravenous LPS injection was preferred in this animal model for examination of the 
inflammatory response. 
In this study 5 mg/kg LPS induced more moderate sepsis-like syndrome compared with 
previous studies of the same animal model (Rosengarten, Hecht et al. 2007; 
Rosengarten, Wolff et al. 2009). The difference in sepsis severity could not be 
explained by difference in the endotoxin, animal body weight, narcotic regime or 
experimental procedure. Even though the same background was used, the rodents in this 
study were ordered from a different distributor, possibly affecting experimental 
outcome. Therefore, it is likely that the weaker response was related to differences 
between animal strains. However, all rats react similar to LPS-injection and developed 
not drastic but moderate sepsis syndrome compared to earlier investigations. 
Higher LPS doses are related to more pronounced sepsis-like syndrome such as 15 
mg/kg LPS showed in Borovikova’s study (Borovikova, Ivanova et al. 2000). 
Neurological recordings are needed to be performed in this study, so higher than 5 
mg/kg LPS would not allow for such measurements over a period of 4.5 hours. 
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Borovikova stopped experiments just 1 hour after LPS application; a much shorter 
duration than our experiments.  
 
4.5. Narcosis with α-chloralose and pancuronium relaxation 
α-Chloralose was chosen as anesthesia because it is believed to have a less depressive 
effect on cardiovascular and respiratory functions as well as on reflex activities. It is 
widely used as a narcotic in the neuroscience field because it provides robust 
hemodynamic responses to functional stimulation such as somatosensory electrical 
stimulation of the forepaw. Compared to other narcotics like halothane or pentobarbital 
used by activation of cerebral metabolic rate of glucose (CMRglc) evoked by forepaw 
electrical stimulation in rats, α-Chloralose effects were most similar to those performed 
on conscious animals (Ueki, Mies et al. 1992). Other studies confirmed that α-
Chloralose is more suitable for studying local cerebral blood flow (lCBF) coupling to 
neuronal functional activation (Wang, Zheng et al. 2008).  
Isoflurane causes both respiratory and cardiovascular depression and stimulates NO-
signaling in the brain, which can influence the measurements. For this reason a washout 
period of one hour was allowed before the start of the experiments. 
α-Chloralose leads typically to myoclonic movements and tonic extensions of the limbs; 
therefore animals were paralyzed with pancuronium bromide. Pancuronium paralyzes 
the skeletal musculature but not the vascular smooth muscle (Nakao, Itoh et al. 2001). 
The use of α-Chloralose as an anesthetic is still controversial because of its long lasting 
analgesic properties, myoclonic effects and blood pressure effects as well as its limited 
reversibility. In this study, animals were sacrificed at the end of the experiments, so 
reversibility of narcosis was not relevant. α-Chloralose slightly induced alkalosis, but 
that did not impact the experiment. This combination of anesthesia was already 
standardized and used successfully in previous experiments using similar animal 
models. 
 
4.6. Effects of VGX STIM and VGX on clinical data  
In this study, neither bilateral vagotomy nor left distal vagal stimulation affected 
drastically the clinical data of non-endotoxinemic animals. That evidence supports the 
hypothesis that left vagus nerve stimulation has a less cardio-depressive effect in 
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regards to heart rate and mean blood pressure. Changes in haemoglobin levels were 
observed. However, these changes were directly caused by infusion of 0.9% NaCl plus 
pancuronium bromide volume administration throughout 4.5 hours measurements in the 
non-endotoxinemic and endotoxinemic groups.  
Occurrence of clinical data changes were observed after LPS administration by rats, 
which were less or more severe according to the LPS-doses (Xu, Qi et al. 1993). Early 
recognition of hemodynamic instability in combination with the complexity of sepsis is 
therefore essential. In this case, doses of intravenously 5 mg/kg LPS caused a moderate 
sepsis-like syndrome with sepsis-related hypotension and increased lactate levels.  
During sepsis, pro-inflammatory cytokines are responsible for increased synthesis of 
vasoactive mediators such as NO, peptide mediators and particularly prostanoids (PGI2, 
PGE2), which cause vasodilation. This results in diminished venous return followed by 
decreases in cardiac pre-load and myocardial depression. Vasoactive mediators that are 
released after sepsis induction cause dilatation of blood vessels and reduction of blood 
pressure. In this study, hypotension occured in all endotoxinemic groups, mainly caused 
by vasodilatatory effect of NO. In more severe cases of sepsis or later time points 
during septic shock, NO levels can rise from 100- to 1000-fold of normal. 
Consequently, it results in a disturbance of oxygen availability to organs, severe 
vasoplegia, myocardial depression, so that drastic derangement of microcirculatory 
supply occurs (Bolton, Young et al. 1993; Vervloet, Thijs et al. 1998; Spronk, Zandstra 
et al. 2004).  
A large number of studies showed increase of blood lactate during sepsis, which is 
generally considered to be an indicator of inadequate oxygenation and a predictive 
marker of fatal outcome. The measurement of blood lactate concentrations is a widely 
used method to detect severity of illness as well as to monitor therapy effects. In the 
present study lactate served to monitor the effect of vagus nerve stimulation as a 
possible protective microcirculatory therapy. Lactate is formed from pyruvate by the 
cytosolic enzyme lactate dehydrogenase. In animal endotoxin models it was shown that 
lactate levels increased when oxygen consumption became dependant on oxygen 
delivery to the tissues, which support its anaerobic origin (Backer 2006). Cytokines, NO 
or endotoxin-induced functional impairment of mitochondria are responsible for the 
resulting inadequate oxidative metabolism. Nearly all tissues of the body rely on the 
aerobic metabolic pathway to produce ATP within the mitochondria in accordance with 
regulation of cellular homeostasis. Microcirculatory alterations are associated with 
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ongoing tissue hypoxia and progression of multiple organ failure. To counteract 
circulatory failure with impaired tissue perfusion some tissues decrease their metabolic 
needs or turn aerobic metabolism into anaerobic metabolism for energy requirement. 
Anaerobic ATP production by itself cannot fulfill the energy needs of the body. Under 
anaerobic conditions there is increased production of hydrogen and lactate ions, which 
are clinically detectable as metabolic acidosis and elevated blood lactate concentrations. 
Occurrence of lactic acidosis contributes to functional failure of the liver and kidneys. 
This outcome is associated with tissue hypoxia and can have lethal effects. Dysoxia 
may be the result of a defect in the cellular utilization of oxygen. In addition, some 
organs produce lactate more than others such as gut and lungs, which notably account 
for sepsis-induced hyperlactatemia. As expected, all sepsis groups in this study showed 
significant increases in the lactate levels after 5 mg/kg LPS administration. However, 
the development of metabolic acidosis was more pronounced by VGX LPS. Besides 
impaired tissue oxygenation, blood lactate levels could be increased by activation of 
glycolysis, decreased lactate clearance, hepatic insufficiency or the presence of oxygen, 
which reduces pyruvate dehydrogenase activity. Moreover endotoxin could deactivate 
the pyruvate dehydrogenase enzyme that moves pyruvate into mitochondria so that 
pyruvate accumulates in the cell cytoplasm where it is converted to lactate (Boldt 2002; 
Kruse 2002 ; Backer 2006).  
However, clinical parameters such as BP and lactate concentrations are indirect clinical 
markers of systemic blood flow, which alone are unreliable estimates of overall 
hemodynamic status during critical illness. 
 
4.7. Effects of VGX STIM and VGX on neurological data 
Microcirculatory failure in the brain under septic condition is less clear. In previous 
studies it was shown that measurements of SEP and latency via electroencephalogram 
(EEG) as well as neurovascular coupling and resting flow velocity recording via LDF 
could be an early prognostic indicator of the systemic inflammatory response. Changes 
in SEPs are sensitive markers for diagnosis of SAD which allow assessment of severity 
and possible outcome of sepsis. It was shown that SEP amplitudes and related EFVR of 
the neurovascular coupling dropped when macrocirculation was still intact 
(Rosengarten, Hecht et al. 2007). Another technique for detection of early 
microcirculatory brain dysfunction is magnetic resonance imaging (MRI). MRI-
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technique was used as a sensitive parameter, but there was no detection of subtle brain 
edema 3.5 hours after sepsis induction. Furthermore, neurovascular coupling 
mechanism and SEP are more reliable for detection of early cerebral dysfunction 
(Zauner, Gendo et al. 2002; Ohnesorge, Bischoff et al. 2003; Rosengarten, Walberer et 
al. 2008). 
The dynamic of neuronal brain activity could be detected by techniques such as EEG 
and magnetoencephalogram (MEG), which are able to follow changes in neural activity 
on a millisecond time-scale. MEG has a poor sensitivity to the radial component of any 
source while EEG is equally sensitive to both radial and tangential source orientations. 
However EEG recording has a stronger sensitivity to electric conductivity and is 
technically easy to replicate by rats compared to MEG.  
However, functional magnetic resonance imaging (fMRI) as a technique reflects the 
blood dynamics through the entire brain using effects of blood oxygenation level 
dependent (BOLD). fMRI has high spatial resolution (13 mm) while temporal 
resolution is about a second which perform a less invasive measurement technique of 
neural activity (Hagler, Halgren et al. 2009). 
For these reasons EEGs were used in this study for detection of neuronal activity 
changes. Additionally the same electrical stimulation was used to analyze blood flow 
changes in sepsis by LDF. In this way, SEP alterations could be analyzed and defined at 
the same time as coupling or uncoupling of the cerebral blood flow nearly from the 
same cortical area. SEPs are performed from EEG-recording via electrical stimulation 
connected to computer. EFVR and resting flow velocity changes are measured by LDF, 
which has been established already as a reliable technique with high temporal and 
spatial resolution for measurements of flow velocity changes during sepsis. Neurodyn 
software was used for the analyses, and results were transferred into Excel for statistical 
analyses, as in previous studies (Rosengarten, Lutz et al. 2003; Rosengarten, Hecht et 
al. 2007).  
Somatosensory potentials may be evoked by contralateral electrical stimulation of the 
forepaw or hindlimb of the rat. In this study the right forepaw stimulation was 
performed as it was evaluated already from previous studies and as it conforms closely 
to brain location of most intensive evoked responses. In addition, the hindlimb was 
cannulated for drug administration and BP recording. Activation of the somatosensory 
cortex can be performed not only by forepaw or hindpaw electrical stimulation, but also 
by whiskers or vibrissae stimulation on rat’s face. Stimulation activates contralateral 
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neurons in the rat cortex, which correspond to an increased blood flow into the area in 
the brain called the barrel cortex. Laboratory rats are nocturnal (night-active) animals, 
which use their sensitive whiskers to explore the environment (Cox, Woolsey et al. 
1993; Mirabella, Battiston et al. 2001). However whisker stimulation cannot be 
transferred to humans as our facial hair does not functionally correlate to rat whiskers. 
Taken together, forepaw stimulation qualifies for investigation of neurovascular 
coupling mechanism and evoked potentials alterations during sepsis. 
The brain is a sensitive organ that reacts immediately against inadequate blood supply 
by inducing systemic inflammation. Microcirculatory disturbances after sepsis induction 
prevents constant glucose and oxygen supply to the cells, which resulted in energy 
deficiency and break down of the membrane potential. This results in nerve cell 
dysfunction as seen in prolonged latencies of SEP responses. Latency gives information 
about the time needed for the cortical nerve cell reaction after stimulus of peripheral 
nerve. During the experiment there was no replacement of the stimulation needles, 
which allows for precise analysis of nerve conductibility. Previous studies showed 
significantly prolonged latency times 4.5 hours after 5 mg/kg LPS induction, which 
occurred after depression of evoked potentials (Rosengarten, Hecht et al. 2007). 
However measurements of latencies in the LPS-groups did not show significant increase 
of nerve conductibility within systemic inflammatory process. This might be related to 
the less severe inflammation in the present animal model.  
Resting flow velocity was analyzed for detection of cerebral hyperaemia. In contrast to 
previous studies where the flow velocity level was approximately 50% higher at the end 
of experiments, in this study cerebral hyperaemia just under 30% among all 
endotoxinemic groups. This may have been due to the decreased severity of 
inflammation and the subsequent weaker induction of iNOS signalling. In previous 
investigations NO-related hyperaemia was shown to exist by administration of selective 
iNOS inhibitors which prevented the occurrence of cerebral hyperaemia (Okamoto, Ito 
et al. 1998; Rosengarten, Hecht et al. 2007). 
Anti- or pro-inflammatory effects of the VGX LPS+STIM or VGX LPS observed in this 
study are consistent with previous studies, further corroborating the hypothesis of a 
“cholinergic anti-inflammatory pathway” (Tracey 2009). There were no nonspecific 
effects observed in the VGX LPS+STIM or VGX LPS as the non-endotoxinemic groups 
showed no significant changes in the neurofunctional parameters. 
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Previous studies report a correlation between the severity of the inflammatory process 
and neurovascular uncoupling by applying different doses of LPS in the same rat model 
(Rosengarten, Hecht et al. 2007). Higher doses of intravenous LPS triggered a more 
pronounced sepsis-like syndrome which led to an earlier and more severe breakdown of 
the NVC followed by an earlier and more pronounced lowering of SEPs. Similar results 
on the microcirculatory function were found in many other organ systems such as the 
gut, the liver, the heart, and the lung (Okamoto, Abe et al. 2000; Pullamsetti, Maring et 
al. 2006; Eyenga, Lhuillier et al. 2010; Dyson, Rudiger et al. 2011). Microcirculatory 
changes occur within several hours after sepsis-induction, initially only loosely 
correlated to systemic hemodynamic alterations. In addition, early microvascular 
alteration preceding systemic hemodynamic changes was also seen under clinical 
conditions (De Backer, Creteur et al. 2002). 
In this study, VGX LPS+STIM prevented the occurrence of early microvascular 
dysfunction in the brain. Comparing both vagal interventions, a significant uncoupling 
of the vascular responses after 180 min was found whereas evoked potentials differed 
only after 4.5 hours. VGX LPS resulted in an earlier and more severe drop in both 
evoked hemodynamic responses and in evoked potential amplitudes, compared to the 
SHAM LPS treated group. VGX LPS+STIM prevented a decline both in the evoked 
potential amplitude and in evoked hemodynamic responses. This means that uncoupling 
of NVC precedes changes in evoked potential amplitudes, which is consistent with early 
studies (Rosengarten, Hecht et al. 2007). 
An increased local inflammation and therefore metabolic rate might also reduce 
substrates and oxygen thereby aggravating the effects of a compromised neurovascular 
coupling. Anyway these positive effects of vagus nerve stimulation might party explain 
improved outcomes of sepsis syndromes. However, morphologic changes such as a 
relevant brain oedema or a breakdown of the blood brain barrier did not play a role 
during the first hours of the present model (Rosengarten, Hecht et al. 2008). 
4.8. Effects of VGX STIM and VGX on lab chemical analysis 
4.8.1. Cytokines 
In the early stage of sepsis, the innate immune system is activated so that not only pro- 
but also anti-inflammatory cytokines are released. The cytokines released affect the 
microcirculation, oxygen utilization, blood brain permeability as well as glucose, 
protein- and neurotransmitter metabolism (Bogdanski, Blobner et al. 1999). As previous 
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studies reported, vagus nerve stimulation has a protective effect by decreasing pro-
inflammatory TNF-α level in plasma and liver, while vagotomy, on the contrary, 
increased TNF-α levels and worsened inflammatory process. In addition, Borovikova 
and colleagues also showed that IL-10 was not influenced by VGX LPS+STIM or VGX 
LPS one hour after LPS-injection in endotoxinemic groups (Borovikova, Ivanova et al. 
2000). That is the reason why cytokines like TNF-α, IL-6, IL-10 and IFN-ǳ were 
examined from plasma samples in this study. Interestingly, cytokines levels did not 
significantly differ within endotoxinemic groups, but rather showed a pro-inflammatory 
tendency in the VGX LPS group and an anti-inflammatory trend in VGX LPS+STIM 
group. This observation is similar to cytokine effects postulated by Borovikova and her 
colleagues. The anti-inflammatory action of VGX LPS+STIM might have been 
effectively controlled by the induction of cytokines and reactive oxygen species which 
can also interfere with the microcirculatory integrity (Abd El-Gawad and Khalifa 2001; 
Gorg, Bidmon et al. 2006). However cytokines can shift astrocytic function from a 
nutritive into an immunostimulating role, causing inflammation in the brain parenchyma 
(Gorg, Bidmon et al. 2006). Moreover astrocytes play an important role in the activation 
of flow coupling (Zonta, Angulo et al. 2003), so that more pronounced cytokine release 
in vagotomy endotoxinemic group (VGX LPS) might explain the earlier drop in evoked 
flow velocity responses and inappropriate blood supply to the neurons.  
 
4.8.2. NO-signalling 
After LPS induction followed by cytokine release, NO-levels increased sharply causing 
hypotension and dissociation of cerebral circulation. In a previous investigation it was 
reported that the specific iNOS inhibitor 1400W stabilized BP, NVC and prevented the 
incidence of cerebral hyperaemia, which supports the hypothesis for a pivotal role of 
NO production related to the occurrence of early vasoregulative failure. Despite 
consistent reports of a stabilization of the microcirculation by iNOS-inhibition, the 
effects on the outcome were inconsistent and in most cases negative. A possible reason 
is that 1400W was found to lead to a dramatic decrease in glucose levels, which only 
appeared in septic but not in non-septic rats. Also a related decrease in SEP occurred, 
which could not be compensated by systemic glucose substitution. This points to an 
intracellular glucose utilization disturbance. The matter needs further clarification as it 
was shown that NO levels can shunt intracellular mitochondrial ATP production. The 
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former studys results were contradicting, as high NO levels were found to inhibit the 
mitochondrial function, whereas blocking of the iNOS preventing increased NO levels 
and led to the drop in potential amplitudes (Tang, Pakula et al. 1996; Vromen, Arkovitz 
et al. 1996; Wray, Millar et al. 1998; Lee, Lin et al. 2005; Rosengarten, Wolff et al. 
2009). 
NO can be induced by pro-inflammatory cytokines such as TNF-α, IL-6, IFN-ǳ. In 
addition its production correlates with changes in iNOS mRNA abundance, especially at 
the pretranslational stage such as transcription or mRNA stability (Morris and Billiar 
1994). Effects of VGX LPS+STIM and VGX LPS on NO production were analyzed on 
mRNA- and protein level from the cortex as well as obtained from plasma samples. 
Lindauer and colleagues previously reported NO acting as a permissive factor in the 
coupling of neuronal activation in the somatosensory cortex of rats (Dreier, Korner et al. 
1995; Lindauer, Megow et al. 1999). However the current study presented evidence that 
the positive effect on the NVC is independent of the NO-pathway, since neither 
nitrite/nitrate level nor the mRNA expression level of iNOS was affected by both vagal 
interventions. The drastically increased iNOS protein level in endotoxinemic vagotomy-
group is probably related to its pro-inflammatory effects. On the other side, higher 
iNOS expression in VGX LPS+STIM-treated animals contrasts with its anti-
inflammatory outcome and can not explain its protective effect on evoked potentials and 
evoked flow velocity responses. Furthermore, there are limited reports suggesting NO 
induction and release by direct stimulation of the vagal nerve. Brack was one of the few 
researchers, who showed NO-related effects of vagus nerve stimulation on the cardiac 
ventricle (Brack, Patel et al. 2009). Although this issue needs further clarification, the 
present data demonstrate that the neuroprotective effect of VGX LPS+STIM cannot be 
explained simply by a decrease in NO. Moreover its protective effect seems to be 
restricted to the microcirculation since macrocirculatory parameters such as the BP and 
the cerebral hyperaemia were not significantly affected by vagal stimulation. However, 
during specific iNOS inhibition BP was stabilized and the development of cerebral 
hyperaemia was prevented, which might confirm limited VGX LPS+STIM effects on 
microcirculation (Rosengarten, Wolff et al. 2009). Another study showed that 
corticosteroids inhibit iNOS expression and NO production during inflammation not 
only directly through epithelial cells, but also indirectly through other cell pathways. 
Nevertheless, a corticosteroid-like anti-inflammatory action appears unlikely as 
Stanka Mihaylova                                  Discussion 
                                                                                         
 
60 
 
corticosteroids significantly reduce the nitrite/nitrate levels and iNOS mRNA 
expression while vagal stimulation did not (Linehan, Kolios et al. 2005). 
Interestingly, NO values were observed even in non endotoxinemic animals. However, 
NO levels were significantly increased only in LPS-treated groups. Due to intensive 
discussions about possible isoflurane NO-up-regulating effects, this study performed a 
NO washout 1 h post isoflurane anaesthesia (Baumane, Dzintare et al. 2002; Sjakste, 
Sjakste et al. 2005). This short isoflurane period during preparation showed less effect 
on iNOS-levels in non endotoxinemic groups (unpublished data). 
The result of a reduced nitrite/nitrate concentration in VGX LPS group contrasts with 
the pro-inflammatory action of vagotomy and the increased protein expression of iNOS. 
Also, in this group was observed the highest lactate level during the earliest 
neurological data collection point indicating a complex regulatory mechanism. However 
this complexity might be explained by hypoxia-related reduction of NO formation. 
Molecular oxygen is basic substrate for NO synthesis by NOS. The Michaelis-Menten 
constant of NOS isoforms are defined within the physiological tissue oxygen 
concentration. Le Cras even suggested that restriction of O2 substrate might limit the 
production of NO in different pathological processes such as hypoxia. So, changes in 
the oxygen concentration may have a rapid effect on NO production (Le Cras and 
McMurtry 2001). Another study reports that NO production by iNOS is dependent on 
O2 availability. Here was shown an example in humans who developed pulmonary 
hypertension by high altitude. This was mainly caused by a reduced NO production due 
to a drop in the pO2 tension (Robinson, Baumgardner et al. 2008). Similar results were 
shown in stroke models, wherein reduced NOS-activity was found in the vital tissue of 
the penumbra and high NOS-activity was partly explained by increased vulnerability in 
ischemia area (Ashwal, Tone et al. 1998). 
 
4.8.3. Hypoxia 
Although measurements of tissue gas tension are potentially useful in critical care 
practice and research, they do not provide a good index of tissue well being. The 
dissociation of the microcirculation in areas of hyper- and hypo-perfusion and a 
fluctuation between states is difficult to measure (Venkatesh and Morgan 2002). It is 
well know that both inducible hypoxic factors HIF-1α and HIF-2α respond to hypoxia 
under non-inflammatory conditions. Some researchers suggest that HIF-2α responses 
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are even long-termed. However HIF-1α and HIF-2α are differently regulated by LPS. 
HIF-1α is rapidly increased under inflammatory conditions independent from normoxic 
or hypoxic environment. In contrast, HIF-2α is not affected by LPS under normoxic 
conditions (Takeda, O'Dea et al. 2010). Under inflammatory conditions, hypoxia-
induced expression of HIF-2α is reduced, making HIF-2α a conservative marker of 
hypoxia under inflammatory conditions. Therefore, hypoxia marker HIF-2α was 
determined and analyzed on the protein level. Increased HIF-2α level in VGX LPS-
group appeared in accordance of both hypoxic and inflammatory condition. 
Takeda described even antagonistic functional properties of HIF-α isoforms in relation 
to NO regulation in inflammatory cells. He concluded that HIF-2α might suppress NO 
production by induction of arginase 1, while HIF-1α might increase NO level by iNOS 
induction. NO production is sensitive to reduced O2 levels. However, this hypoxic 
condition may partly contribute to decreased NO-levels in plasma samples in VGX 
LPS-group (Takeda, O'Dea et al. 2010). 
Neurons are very sensitive to a chronic disturbance in cerebral blood flow. A chronic 
lowering of the ideal cerebral blood flow by 10% to 20% leads to protein synthesis 
inhibition, activation of anaerobic glycolysis followed by release of neurotransmitters, 
and dysfunction of neurons within a few hours. Overall, there is less energy for 
metabolic processes (Hossmann 1994). Inadequate oxygen and substrate supply might 
influence EEG activity and cause a drop in evoked potential amplitudes. Similar 
responses in evoked potentials were found already in different hypoxic states of the 
brain, independent of inflammation. For example, Arezzo and colleagues reported 
changes in SEP after exposure to carbon monoxide and acrylamide. Anoxic coma after 
cardiac arrest also resulted in evoked potential (EP) alterations in comatose patients 
(Arezzo, Simson et al. 1985; Daubin, Guillotin et al. 2008). Moreover, pathological 
brain analysis showed that 95% of sepsis patients have diffuse cerebral ischemic 
damage during the course of the disease. MRIs made early detection of sepsis-related 
brain lesions such as microinfarcts possible, which were mainly located in the white 
matter (Sharshar, Annane et al. 2004; Sharshar, Carlier et al. 2007). Additionally, 
patients who survive sepsis give signs of typical brain changes and are clinically similar 
to patients with cardiac resuscitation or carbon monoxide intoxication. This was 
associated with cognitive and functional limitations as well as neuropsychological 
impairment, which was in accordance with the sepsis-induced brain lesion (Devine, 
Kirkley et al. 2002; Harve, Tiainen et al. 2007; Iwashyna, Ely et al. 2010). However, it 
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seems that observed hypoxia in VGX LPS group is more likely localized then 
generalized. In addition, this result is supported by clinical data, which indicate 
sufficient macrocirculatory and pulmonary functioning. 
 
4.8.4. Apoptosis  
To provide insight into possible early effects of vagus nerve stimulation and vagotomy 
on apoptotic cell death, BAX mRNA level expression was investigated. Recently, it was 
shown that the protein-levels of BAX- and BCL-related pro- and anti-apoptotic 
pathways were not induced until 8 h of sepsis induction. In addition, histological 
changes of BAX- and BCL-2-immunoreactive cells were first observed after 24 h 
(Semmler, Okulla et al. 2005). Here BAX mRNA expression was not significantly 
changed within endotoxinemic and non-endotoxinemic groups at that early stage of 
sepsis, which supports data from previous studies. Moreover this study examines and 
accommodates the dynamic of sepsis development. Messaris and colleagues showed 
mitochondrial-mediated apoptosis in the rat brain early in sepsis development. At an 
early stage, 6 to 12 hours after sepsis induction, BAX immunoreactivity was 
upregulated (Messaris, Memos et al. 2004). However in our study mitochondrial 
dysfunction appears more unlikely as animals were subjected to 4.5 hours of sepsis 
(Comim, Rezin et al. 2008). Our study confirmed previous studies showing that 
apoptotic parameters are still not significantly expressed 4.5 hours after LPS injection.  
 
 
Stanka Mihaylova                                    Summary 
                                                                                         
 
63 
 
 
5. SUMMARY 
 
Sepsis is the most frequent cause of death in all intensive care units. It is characterized 
as a hyper-inflammatory host response including NO-related microcirculatory 
dysfunction leading to catecholamine-resistant shock. It leads also to macrocirculatory 
disorganisation and disturbance in organ perfusion. The brain is especially susceptible 
to an insufficient blood supply. It has been shown that vagus nerve stimulation mitigates 
inflammation and possibly improves the outcome of sepsis. This study presents the 
effects of vagus nerve stimulation on the integrity of cerebral microcirculation.  
The neurovascular coupling in the somatosensory cortex was studied in ventilated and 
sedated rats by applying electrical forepaw stimulation and EEG and transcranial LDF 
recording. In both control and endotoxinemic rats, the effect of bilateral vagotomy, 
vagotomy with left sided distal vagus nerve stimulation, and a sham group were 
compared. Resting LDF, evoked potentials and hemodynamic responses were obtained 
over a period of 4.5 h. Regulation of NO signalling was assessed at the end of the 
experiment by analysing iNOS expression and nitrite/nitrate measurements, cytokines 
(IFN-γ, TNF-α, IL-6, IL-10), hypoxic signalling molecules such as HIF-2α and the 
apoptosis molecule, Bax.  
The occurrence of a cerebral microvascular failure depends on the severity of the pro-
inflammatory phase of inflammation. Endotoxin induced a moderate sepsis-like 
syndrome with typical macrocirculatory changes such as a decrease in blood pressure 
and the occurrence of slight cerebral hyperaemia. Time-dependent microcirculatory 
dysfunction with uncoupling and depression of evoked potentials were observed. 
Without inhibition of NO signalling, vagal stimulation stabilized neurovascular 
coupling, evoked potentials and showed anti-inflammatory tendency on cytokine levels. 
The positive effects on evoked potential amplitudes may partly explain better outcomes 
of sepsis syndrome. Vagotomy contributed to severe inflammation resulting in a 
hypoxic state, as indicated by increased HIF-2α levels. Current results from vagus nerve 
stimulation and vagotomy even corroborate Tracy’s hypothesis of a “cholinergic anti-
inflammatory pathway”. 
In conclusion, vagus nerve stimulation protects against early cerebral microcirculatory 
failure, which has relevance for neuronal integrity. Furthermore, the effects were not 
related to an inhibition of NO signalling. 
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6. ZUSAMMENFASSUNG 
 
Sepsis wird durch eine überempfindliche Reaktion des Wirts gekennzeichnet, die den 
Einfluss von Stickstoffmonoxid (NO) auf die Mikrozirkulationsstörung beinhaltet, was 
zu einem katecholamine-resistenten Schock führt. Es kommt auch zur 
makrozirkulatorischen Störung und damit verbundenen Perfusionsstörungen der 
Organe. Das Gehirn ist sehr empfindlich gegenüber inadäquater Durchblutung. Distale 
Vagusnerv-Stimulation mildert das Entzündungsgeschehen und verbessert 
möglicherweise das Ergebnis der Sepsis. Diese Studie stellt die Auswirkungen der 
Vagusnerv-Stimulation auf die Integrität der zerebralen Mikrozirkulation dar. 
Hierzu wird die neurovaskuläre Kopplung vom somatosensorischen Kortex bei 
beatmeten und sedierten Ratten durch elektrische Stimulation der Vorderpfote, EEG- 
sowie transkranielle Laser-Doppler-Flussmessung erfasst. Bei den nicht-septischen und 
septischen Ratten wurde die Wirkung der bilateralen Vagotomie, Vagotomie mit 
linksseitiger distaler Vagusnerv-Stimulation und einer Placebo-Gruppe verglichen. Das 
ruhe LDF Signal, die evozierten Potentiale und hämodynamischen Reaktionen wurden 
über einen Zeitraum von 4,5 Std. gemittelt. Der Effekt auf das NO-System wurde am 
Ende des Experiments durch die Analyse von iNOS-Expression und Nitrit/Nitrat-
Messungen erfasst sowie die Zytokine (IFN-γ, TNF-α, IL-6, IL-10), hypoxischen 
Signalmoleküle wie HIF-2α und Apoptose-Moleküle Bax bewertet. 
Das Auftreten eines zerebralen mikrovaskulären Versagens ist  von der Schwere der 
entzündungsfördernden Phase der Erkrankung abhängig. Endotoxin induziert ein 
moderates sepsis-assoziiertes Syndrom mit typischen makrozirkulatorischen 
Veränderungen wie z.B. Senkung des Blutdrucks und schwaches Auftreten von 
zerebraler Hyperämie. Des Weiteren wurden zeitabhängige mikrozirkulatorische 
Störungen  mit Entkopplung und Depression der evozierten Potentiale beobachtet. 
Zusätzlich zu den entzündungshemmenden Tendenzen auf den Zytokinspiegel, 
stabilisiert die Stimulation des Vagusnervs die neurovaskuläre Kopplung und evozierte 
Potentiale ohne hemmenden Einfluss auf das Stickstoffmonoxid-System. Die positive 
Auswirkung auf die evozierten Potentiale könnte teilweise das Ergebnis der Sepsis 
erklären. Vagotomie ist assoziiert mit schweren Entzündungen, was zu einem 
hypoxischen Zustand führt, gezeigt durch die Erhöhung der HIF-2α Werte. Die 
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Ergebnisse von Vagotomie und Vagusnerv-Stimulation unterstützen sogar die 
Hypothese von Tracey eines "cholinergen entzündungshemmenden Wegs". 
Zum Schluss kann gesagt werden, dass die Vagusnerv-Stimulation vor zerebralem 
Mikrozirkulationsversagen schützt, welches die neuronale Integrität gefährdet. Zudem 
ist anzumerken, dass die Vagusnerv-Stimulation keinem Effekt auf das NO-System hat. 
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7. ABBREVIATIONS 
°C  Centigrade 
∆∆Ct   Delta-delta Ct 
%  Percent 
ACCP   American College of Chest Physicians  
Ach   Acetylcholine  
A. femoralis Arteria femoralis 
ANS   Autonomic nervous system  
APS   Ammonium persulfate  
ATP   Adenosine triphosphate 
AV   Atrioventricular  
bp   Base pairs  
BP  Blood pressure 
BSA   Bovine serum albumin  
CBF   Cerebral blood flow 
cDNA  Complementary deoxyribonucleic acid 
ccm  Cubic centimeter 
CLP   Cecal ligation and puncture  
cm  Centimeter 
CMRglc  Cerebral metabolic rate of glucose 
CNS   Central nervous system  
Ct   Threshold cycle 
DIC   Disseminated intravascular coagulation  
dl  Deciliter 
DMSO  Dimethyl sulfoxide 
dNTP   Deoxyribonucleotide triphosphate 
DSM   Diagnostic and Statistical Manual  
E.coli  Escherichia coli 
EEG  Electroencephalogram 
EFVR  Evoked flow velocity responses 
eNOS   Endothelium nitric oxide synthase 
EP  Evoked potential 
ER  Endoplasmic reticulum 
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fMRI   Functional magnetic resonance imaging  
FasL  Fas ligand 
g   Gram 
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase 
h   Hour(s) 
Hz  Hertz  
ICU  Intensive Care Unit 
IFN-ǳ  Interferon-ǳ 
IL   Interleukin  
iNOS   Inducible nitric oxide synthase 
i.v.  Intravenous 
kDa   Kilo Dalton 
kg  Kilogram 
L  Liter 
lCBF   Local cerebral blood flow  
LDF   Laser-Doppler-Flowmetry 
LPS   Lipopolysaccharide   
µg   Microgram 
min  Minute 
µl   Microliter 
µm   Micrometer 
µM   Micromolar 
M   Molar 
mA  Milliampere  
mg  Milligram 
ml  Milliliter 
mm3  Cubic Millimeter 
mM   Millimolar 
Mmol  Millimol 
min  Minute 
mm  Millimeter  
mmHg  Millimeter of mercury 
ms   Milliseconds 
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MEG   Magnetoencephalogram  
MHC   Major Histocompatibility complex  
MODS  Multiple Organ Dysfunction Syndrome  
N  Newton 
NaCl  Sodium chloride 
N. femoralis Nervus femoralis 
NF-κB   Nuclear factor kappa-light-chain-enhancer of activated B cells  
nl  Nanoliter 
NLRs   Nod-like receptors  
nm   Nanometer 
nM   Nanomolar  
N2O   Nitrous oxide  
NO   Nitric oxide  
NOS   Nitric oxide synthase 
n.s  Not significant 
PO2  Partial oxygen pressure  
PaCO2  Partial pressure of carbon dioxide  
PAGE   Polyacrylamide gel electrophoresis 
PAF   Platelet-activating factor 
PBGD  Porphobilinogen deaminase  
PBS   Phosphate-buffered saline 
PCR   Polymerase chain reaction  
PIRO   Predisposition Infection Response and Organ Dysfunction 
PEEP  Positive Endexpiratory Pressure 
PGE  Prostaglandine 
PMN  Polymorphonuclear  
PMSF   Phenylmethylsulfonyl fluoride 
PNS  Peripheral nervous system 
PRRs  Pattern recognition receptors 
qRT-PCR  Quantitative real time-polymerase chain reaction  
rCBF  Regional cerebral blood flow 
RLRs   RIG-I (retinoic acid-inducible gene-I)-like receptors 
RNA   Ribonucleic acid  
Rpm  Revolution per minute 
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RT-PCR Reverse transcriptase-polymerase chain reaction 
s  Seconds   
SCCM  Society of Critical Care Medicine 
SD   Standard deviation  
SAD   Sepsis-associated delirium  
SDS   Sodium dodecyl sulfate 
SEP  Somatosensory evoked potential 
SIRS   Systemic inflammatory response syndromes 
TBST   Tris-buffered saline buffer+ 0.1% Tween 20  
TC cells T cytotoxic cells  
TH cells T helper cells 
TEMED  N,N',N'-tetramethyl-ethane-1,2-diamine 
TLRs   Toll-like receptors 
TNF-α  Tumor necrosis factor α  
Tris  Tris-(hydroxy methyl)-amino methane APS 10% (w/v)   
TS cells T suppressor cells 
V   Volt  
V. femoralis Vena femoralis 
VGX   Bilateral vagotomy 
VGX+STIM  Bilateral vagotomy and distal vagus nerve stimulation 
vs.  Versus 
WBC  White blood cell 
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